Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases
Nonalcoholic fatty liver disease (NAFLD) is a global health concern associated with significant morbidity and mortality. NAFLD is a spectrum of diseases originating from simple steatosis, progressing through nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis that may lead to hepatocellular...
Saved in:
Published in | Hepatobiliary & pancreatic diseases international Vol. 22; no. 4; pp. 333 - 345 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Singapore
Elsevier B.V
01.08.2023
Department of Pharmacology,Molecular Medicine and Toxicology Lab,Saveetha Dental College,Saveetha Institute of Medical and Technical Sciences(SIMATS),Chennai,Tamil Nadu 600077,India |
Subjects | |
Online Access | Get full text |
ISSN | 1499-3872 |
DOI | 10.1016/j.hbpd.2022.10.003 |
Cover
Abstract | Nonalcoholic fatty liver disease (NAFLD) is a global health concern associated with significant morbidity and mortality. NAFLD is a spectrum of diseases originating from simple steatosis, progressing through nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis that may lead to hepatocellular carcinoma (HCC). The pathogenesis of NAFLD is mediated by the triglyceride accumulation followed by proinflammatory cytokines expression leading to inflammation, oxidative stress, and mitochondrial dysfunction denoted as “two-hit hypothesis”, advancing with a “third hit” of insufficient hepatocyte proliferation, leading to the increase in hepatic progenitor cells contributing to fibrosis and HCC. Wnt/β-catenin signaling is responsible for normal liver development, regeneration, hepatic metabolic zonation, ammonia and drug detoxification, hepatobiliary development, etc., maintaining the overall liver homeostasis. The key regulators of canonical Wnt signaling such as LRP6, Wnt1, Wnt3a, β-catenin, GSK-3β, and APC are abnormally regulated in NAFLD. Many experimental studies have shown the aberrated Wnt/β-catenin signaling during the NAFLD progression and NASH to hepatic fibrosis and HCC. Therefore, in this review, we have emphasized the role of Wnt/β-catenin signaling and its modulators that can potentially aid in the inhibition of NAFLD. |
---|---|
AbstractList | Nonalcoholic fatty liver disease (NAFLD) is a global health concern associated with significant morbidity and mortality. NAFLD is a spectrum of diseases originating from simple steatosis, progressing through nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis that may lead to hepatocellular carcinoma (HCC). The pathogenesis of NAFLD is mediated by the triglyceride accumulation followed by proinflammatory cytokines expression leading to inflammation, oxidative stress, and mitochondrial dysfunction denoted as "two-hit hypothesis", advancing with a "third hit" of insufficient hepatocyte proliferation, leading to the increase in hepatic progenitor cells contributing to fibrosis and HCC. Wnt/β-catenin signaling is responsible for normal liver development, regeneration, hepatic metabolic zonation, ammonia and drug detoxification, hepatobiliary development, etc., maintaining the overall liver homeostasis. The key regulators of canonical Wnt signaling such as LRP6, Wnt1, Wnt3a, β-catenin, GSK-3β, and APC are abnormally regulated in NAFLD. Many experimental studies have shown the aberrated Wnt/β-catenin signaling during the NAFLD progression and NASH to hepatic fibrosis and HCC. Therefore, in this review, we have emphasized the role of Wnt/β-catenin signaling and its modulators that can potentially aid in the inhibition of NAFLD.Nonalcoholic fatty liver disease (NAFLD) is a global health concern associated with significant morbidity and mortality. NAFLD is a spectrum of diseases originating from simple steatosis, progressing through nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis that may lead to hepatocellular carcinoma (HCC). The pathogenesis of NAFLD is mediated by the triglyceride accumulation followed by proinflammatory cytokines expression leading to inflammation, oxidative stress, and mitochondrial dysfunction denoted as "two-hit hypothesis", advancing with a "third hit" of insufficient hepatocyte proliferation, leading to the increase in hepatic progenitor cells contributing to fibrosis and HCC. Wnt/β-catenin signaling is responsible for normal liver development, regeneration, hepatic metabolic zonation, ammonia and drug detoxification, hepatobiliary development, etc., maintaining the overall liver homeostasis. The key regulators of canonical Wnt signaling such as LRP6, Wnt1, Wnt3a, β-catenin, GSK-3β, and APC are abnormally regulated in NAFLD. Many experimental studies have shown the aberrated Wnt/β-catenin signaling during the NAFLD progression and NASH to hepatic fibrosis and HCC. Therefore, in this review, we have emphasized the role of Wnt/β-catenin signaling and its modulators that can potentially aid in the inhibition of NAFLD. Nonalcoholic fatty liver disease (NAFLD) is a global health concern associated with significant morbidity and mortality. NAFLD is a spectrum of diseases originating from simple steatosis, progressing through nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis that may lead to hepatocellular carcinoma (HCC). The pathogenesis of NAFLD is mediated by the triglyceride accumulation followed by proinflammatory cytokines expression leading to inflammation, oxidative stress, and mitochondrial dysfunction denoted as “two-hit hypothesis”, advancing with a “third hit” of insufficient hepatocyte proliferation, leading to the increase in hepatic progenitor cells contributing to fibrosis and HCC. Wnt/β-catenin signaling is responsible for normal liver development, regeneration, hepatic metabolic zonation, ammonia and drug detoxification, hepatobiliary development, etc., maintaining the overall liver homeostasis. The key regulators of canonical Wnt signaling such as LRP6, Wnt1, Wnt3a, β-catenin, GSK-3β, and APC are abnormally regulated in NAFLD. Many experimental studies have shown the aberrated Wnt/β-catenin signaling during the NAFLD progression and NASH to hepatic fibrosis and HCC. Therefore, in this review, we have emphasized the role of Wnt/β-catenin signaling and its modulators that can potentially aid in the inhibition of NAFLD. Nonalcoholic fatty liver disease(NAFLD)is a global health concern associated with significant morbidity and mortality.NAFLD is a spectrum of diseases originating from simple steatosis,progressing through nonalcoholic steatohepatitis(NASH),fibrosis,and cirrhosis that may lead to hepatocellular carcinoma(HCC).The pathogenesis of NAFLD is mediated by the triglyceride accumulation followed by proinflam-matory cytokines expression leading to inflammation,oxidative stress,and mitochondrial dysfunction de-noted as"two-hit hypothesis",advancing with a"third hit"of insufficient hepatocyte proliferation,lead-ing to the increase in hepatic progenitor cells contributing to fibrosis and HCC.Wnt/β-catenin signaling is responsible for normal liver development,regeneration,hepatic metabolic zonation,ammonia and drug detoxification,hepatobiliary development,etc.,maintaining the overall liver homeostasis.The key regula-tors of canonical Wnt signaling such as LRP6,Wnt1,Wnt3a,β-catenin,GSK-3 β,and APC are abnormally regulated in NAFLD.Many experimental studies have shown the aberrated Wnt/β-catenin signaling dur-ing the NAFLD progression and NASH to hepatic fibrosis and HCC.Therefore,in this review,we have em-phasized the role of Wnt/β-catenin signaling and its modulators that can potentially aid in the inhibition of NAFLD. |
Author | Ezhilarasan, Devaraj Shree Harini, Karthik |
AuthorAffiliation | Department of Pharmacology,Molecular Medicine and Toxicology Lab,Saveetha Dental College,Saveetha Institute of Medical and Technical Sciences(SIMATS),Chennai,Tamil Nadu 600077,India |
AuthorAffiliation_xml | – name: Department of Pharmacology,Molecular Medicine and Toxicology Lab,Saveetha Dental College,Saveetha Institute of Medical and Technical Sciences(SIMATS),Chennai,Tamil Nadu 600077,India |
Author_xml | – sequence: 1 givenname: Karthik surname: Shree Harini fullname: Shree Harini, Karthik – sequence: 2 givenname: Devaraj surname: Ezhilarasan fullname: Ezhilarasan, Devaraj email: ezhild@gmail.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36448560$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1uFDEQhb0IIj9wARaol0hoJrbb0z-IDYpIQIrEJhFLq9qu7rjx2IPtTjSz4gg5Y06CR51sskhWVSq_r1x675gcOO-QkA-MLhll1em4vOk2eskp53mwpLQ8IEdMtO2ibGp-SI5jHCnlTbOq3pLDshIid_SIXP126bTDBA__7hUkdMYV0QwOrHFDAU4XJsVi7fVkIfkQi_yevwar_I23RhU9pLQtrLnFUGgTESLGd-RNDzbi-8d6Qq7Pv1-d_Vhc_rr4efbtcqGEKNMCOVOsUtUK604LDm3f9rTrNKgear1ivKdl3eiaqaZiraY1F5pT1uiy6mgDojwhn-e9d-B6cIMc_RTybVEO46C33W4nd9mRkorsR1Z_mtWb4P9OGJNcm6jQWnDopyh5LcoVrdu2zdKPj9KpW6OWm2DWELbyybcsaGaBCj7GgL1UJkEy3qUAxkpG5T4WOcp9LHIfy342n8GfoU_bX4S-zhBmO28NBhmVQadQm4AqSe3Ny_iXZ7jK-RoF9g9uX4P_A_h-vOQ |
CitedBy_id | crossref_primary_10_1038_s41467_024_51860_2 crossref_primary_10_3389_fendo_2023_1148934 crossref_primary_10_3390_ijms241713326 crossref_primary_10_1016_j_intimp_2024_112821 crossref_primary_10_1016_j_fct_2025_115241 crossref_primary_10_1002_tox_24465 crossref_primary_10_1016_j_isci_2024_110382 crossref_primary_10_3389_fendo_2024_1344376 crossref_primary_10_1016_j_bbadis_2024_167555 crossref_primary_10_1016_j_jcmgh_2023_10_009 crossref_primary_10_1016_j_cca_2024_117892 crossref_primary_10_1021_acs_jnatprod_4c00742 crossref_primary_10_1016_j_hbpd_2023_02_004 crossref_primary_10_1111_jgh_16874 crossref_primary_10_3389_fmed_2024_1454980 crossref_primary_10_2147_JIR_S497737 crossref_primary_10_1016_j_jddst_2024_105467 crossref_primary_10_3389_fgene_2023_1070605 |
Cites_doi | 10.1073/pnas.1006437108 10.1111/cpr.12161 10.1038/35035124 10.18632/oncotarget.12774 10.1073/pnas.1205015109 10.1210/jc.2012-3038 10.1016/j.cyto.2020.155250 10.1007/s11892-009-0034-5 10.1146/annurev-immunol-030409-101311 10.1038/nrgastro.2010.168 10.1073/pnas.1120068109 10.1136/gutjnl-2012-303816 10.1002/hep.20283 10.1172/JCI63539 10.1136/bmj.d3897 10.1038/ncomms1680 10.1053/jhep.2001.23786 10.1016/j.freeradbiomed.2009.07.016 10.7861/clinmedicine.15-6-s77 10.1096/fj.15-271171 10.1126/science.1188280 10.1016/j.cell.2010.07.041 10.1371/journal.pone.0120919 10.1055/s-0028-1091981 10.1016/j.bbrc.2005.03.007 10.1038/nature02924 10.1016/j.cbi.2007.09.003 10.1002/pro.3122 10.1016/j.jhep.2006.02.011 10.1016/j.cld.2017.08.003 10.1016/j.jhep.2006.03.016 10.1177/1479164117738442 10.1016/j.jhep.2014.12.012 10.1007/s13277-012-0331-5 10.1002/hep.23801 10.1038/nrd2154 10.1186/1471-2458-10-237 10.1158/0008-5472.CAN-15-1519 10.1186/s12916-017-0806-8 10.1016/j.cellsig.2013.09.016 10.5009/gnl.2014.8.3.282 10.1097/MOG.0000000000000176 10.1093/emboj/16.13.3797 10.3390/nu7064453 10.1097/MAJ.0b013e3181812879 10.1038/nrm2391 10.1136/pgmj.74.870.193 10.1053/j.gastro.2003.12.047 10.1158/0008-5472.CAN-10-3342 10.1016/j.biopha.2020.110661 10.1126/science.289.5481.950 10.1111/j.1747-0285.2011.01295.x 10.3748/wjg.v20.i26.8393 10.1002/hep.26924 10.1016/j.bpg.2011.02.005 10.1007/s00439-013-1294-3 10.1053/j.gastro.2006.08.042 10.3892/mmr.2016.5148 10.1038/s41591-018-0104-9 10.1002/jcp.30582 10.1055/s-2005-858989 10.1002/jcp.22593 10.1042/cs0920103 10.1371/journal.pone.0015521 10.1074/jbc.M313478200 10.1016/j.apsb.2017.10.003 10.1016/j.metabol.2015.12.012 10.1016/j.mito.2005.10.004 10.1016/S0016-5085(98)70599-2 10.1007/s11010-012-1498-1 10.1016/j.canlet.2009.06.009 10.1016/S0959-8049(16)32668-5 10.2174/138161210791208875 10.3389/fnut.2021.791861 10.1016/j.semcancer.2010.12.010 10.3727/096504017X14992942781895 10.3748/wjg.v24.i27.2974 10.1016/j.jpeds.2012.08.043 10.3748/wjg.v16.i34.4243 10.1097/CCO.0000000000000042 10.1002/hep.28431 10.1016/j.jhep.2009.03.019 10.1177/1535370220949148 10.1136/gutjnl-2014-308969 10.1371/journal.pone.0081710 10.1016/j.cellsig.2017.06.001 10.1634/theoncologist.2012-0211 10.1136/gut.2008.161885 10.1038/ng1732 10.1371/journal.pone.0157246 10.1074/jbc.M410078200 10.1016/S0016-5085(96)70028-8 10.1016/j.jhep.2005.03.004 10.1016/S0002-9440(10)61215-1 10.1002/hep.21131 10.1002/hep.21473 10.1111/j.1572-0241.1999.01377.x 10.1152/ajpgi.00263.2007 10.1016/S0002-9440(10)63489-X 10.1038/nm.3699 10.1128/CMR.12.1.40 10.1074/jbc.M111.286724 10.1093/emboj/18.15.4233 10.3748/wjg.v18.i15.1745 10.1136/gut.2005.071118 10.1126/scisignal.2001249 10.1158/1535-7163.MCT-13-0048 10.1186/s13046-018-0678-6 10.1016/S0024-3205(00)00605-6 10.1016/j.febslet.2007.05.050 10.1038/onc.2015.280 10.4161/epi.5.8.13104 10.1053/j.gastro.2015.02.056 10.1172/JCI34275 10.1074/jbc.M310284200 10.1002/hep.22084 10.1006/jaut.2001.0522 10.1007/s11596-019-2123-2 10.3892/mmr.2014.2099 10.1038/sj.onc.1206118 10.1371/journal.pone.0083819 10.1074/jbc.M109.009647 10.3748/wjg.v22.i48.10512 10.1038/nature05485 10.1021/bi0512602 10.1242/dmm.001180 10.1038/nrgastro.2013.41 10.1053/j.gastro.2010.03.052 10.1016/j.bbadis.2017.12.001 10.1016/j.metabol.2016.06.009 10.1016/j.lfs.2003.07.017 10.1158/0008-5472.CAN-14-2041 10.1002/hep.23337 10.1038/ng.257 10.1016/j.cld.2009.07.005 10.1152/ajpgi.90223.2008 10.1016/j.jphs.2018.01.003 10.1111/j.1572-0241.2004.30159.x 10.1016/j.bcp.2020.113942 10.1007/s00418-008-0546-0 10.1053/j.gastro.2008.03.003 10.2353/ajpath.2010.090667 10.1155/2020/4910601 10.1038/nrgastro.2017.109 10.1016/j.biopha.2018.11.149 10.1016/j.jhep.2010.04.008 10.7150/ijbs.14718 10.1038/nm1166 10.1158/0008-5472.CAN-14-3786 10.1016/j.taap.2014.03.008 10.1073/pnas.1119964109 |
ContentType | Journal Article |
Copyright | 2022 Copyright © 2022. Published by Elsevier B.V. Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
Copyright_xml | – notice: 2022 – notice: Copyright © 2022. Published by Elsevier B.V. – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
DBID | AAYXX CITATION NPM 7X8 2B. 4A8 92I 93N PSX TCJ |
DOI | 10.1016/j.hbpd.2022.10.003 |
DatabaseName | CrossRef PubMed MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EndPage | 345 |
ExternalDocumentID | gjgdybzz_z202304003 36448560 10_1016_j_hbpd_2022_10_003 S1499387222002399 |
Genre | Journal Article Review |
GroupedDBID | --- --K -05 -0E -SE -S~ .1- .FO .~1 0R~ 1P~ 1~. 2WC 4.4 457 4G. 53G 5GY 5VR 7-5 8RM 92F 92I 92M 9D9 9DE AAEDT AAEDW AAKOC AALRI AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABKZE ABMAC ABWVN ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADCNI ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFPUW AFRHN AFTJW AFUIB AFXIZ AGCQF AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BNPGV C1A CAJEE CCEZO CHBEP CIEJG DIK EBS EFJIC EFKBS EJD F5P FDB FIRID FNPLU FRP FYGXN GBLVA GX1 HZ~ JUIAU KOM M41 MO0 O-L O9- OC. OK1 P-8 P-9 P6G PC. Q-- Q-4 Q38 ROL RT5 S.. SDF SES SPCBC SSH SSZ T5K T8U TCJ TGQ U1F U1G U5E U5O W2D WFFXF Z5R ~G- 188 2B. 2C~ 93N 93R AACTN AAIAV ABLVK ABYKQ AFCTW AFKWA AJBFU CAJUS EFLBG FA0 R-E RIG UZ5 AAYXX AGRNS CITATION NPM 7X8 ACLOT ~HD 4A8 PSX |
ID | FETCH-LOGICAL-c443t-e21c16c65e7bd42a9f9f0bbdacfa7d512f0378d71c8619d0724d2018d36b08a43 |
IEDL.DBID | AIKHN |
ISSN | 1499-3872 |
IngestDate | Thu May 29 04:07:36 EDT 2025 Sat Sep 27 20:27:06 EDT 2025 Mon Jul 21 06:00:37 EDT 2025 Tue Jul 01 01:41:32 EDT 2025 Thu Apr 24 23:04:01 EDT 2025 Fri Feb 23 02:34:57 EST 2024 Tue Aug 26 16:37:34 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Oxidative stress Chronic liver diseases Fatty liver Wnt/β-catenin Fibrosis Steatosis |
Language | English |
License | Copyright © 2022. Published by Elsevier B.V. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c443t-e21c16c65e7bd42a9f9f0bbdacfa7d512f0378d71c8619d0724d2018d36b08a43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
PMID | 36448560 |
PQID | 2743507999 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | wanfang_journals_gjgdybzz_z202304003 proquest_miscellaneous_2743507999 pubmed_primary_36448560 crossref_citationtrail_10_1016_j_hbpd_2022_10_003 crossref_primary_10_1016_j_hbpd_2022_10_003 elsevier_sciencedirect_doi_10_1016_j_hbpd_2022_10_003 elsevier_clinicalkey_doi_10_1016_j_hbpd_2022_10_003 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-08-01 |
PublicationDateYYYYMMDD | 2023-08-01 |
PublicationDate_xml | – month: 08 year: 2023 text: 2023-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Singapore |
PublicationPlace_xml | – name: Singapore |
PublicationTitle | Hepatobiliary & pancreatic diseases international |
PublicationTitleAlternate | Hepatobiliary Pancreat Dis Int |
PublicationTitle_FL | Hepatobiliary & Pancreatic Diseases International |
PublicationYear | 2023 |
Publisher | Elsevier B.V Department of Pharmacology,Molecular Medicine and Toxicology Lab,Saveetha Dental College,Saveetha Institute of Medical and Technical Sciences(SIMATS),Chennai,Tamil Nadu 600077,India |
Publisher_xml | – name: Elsevier B.V – name: Department of Pharmacology,Molecular Medicine and Toxicology Lab,Saveetha Dental College,Saveetha Institute of Medical and Technical Sciences(SIMATS),Chennai,Tamil Nadu 600077,India |
References | Kim, Kisseleva, Brenner (bib0009) 2015; 31 Kanazawa, Tsukada, Kamiyama, Yanagimoto, Nakajima, Maeda (bib0145) 2005; 330 Yeh, Krauland, Singh, Zou, Devaraj, Stolz (bib0074) 2010; 52 Ackers, Malgor (bib0076) 2018; 15 Fang, Hou, Chang, Hsiu, Chao, Chiang (bib0148) 2003; 74 Ross, Hemati, Longo, Bennett, Lucas, Erickson (bib0096) 2000; 289 Behari, Yeh, Krauland, Otruba, Cieply, Hauth (bib0087) 2010; 176 Madan, Ke, Harmston, Ho, Frois, Alam (bib0141) 2016; 35 Gougelet, Sartor, Bachelot, Godard, Marchiol, Renault (bib0113) 2016; 65 Aragno, Tomasinelli, Vercellinatto, Catalano, Collino, Fantozzi (bib0023) 2009; 47 Hazra, Xiong, Wang, Rippe, Krishna, Chatterjee (bib0097) 2004; 279 Liu, Fergusson, Wu, Rovira, Liu, Gavrilova (bib0082) 2011; 4 Friedman (bib0056) 2008; 134 Brunt, Janney, Di Bisceglie, Neuschwander-Tetri, Bacon (bib0003) 1999; 94 Cohen, Stemmer, Zozulya, Ochaion, Patoka, Barer (bib0130) 2011; 226 Roskams, Yang, Koteish, Durnez, DeVos, Huang (bib0032) 2003; 163 Micsenyi, Tan, Sneddon, Luo, Michalopoulos, Monga (bib0066) 2004; 126 Fako, Yu, Henrich, Ransom, Budhu, Wang (bib0133) 2016; 12 Ge, Wang, Wu, Fan, Chen (bib0094) 2014; 9 Younossi, Anstee, Marietti, Hardy, Henry, Eslam (bib0004) 2018; 15 Nejak-Bowen, Monga (bib0070) 2011; 21 Du, Ren, Zhang, Fu, Han, Cui (bib0101) 2020; 2020 de la Roche, Rutherford, Gupta, Veprintsev, Saxty, Freund (bib0117) 2012; 3 Pinson, Brennan, Monkley, Avery, Skarnes (bib0062) 2000; 407 Zhang, Pan, Zhang, Yan, Yu, Wu (bib0100) 2013; 374 Wang, Wang, Huang, Chen, Lü, Shi (bib0077) 2019; 44 Kotronen, Yki-Järvinen, Männistö, Saarikoski, Korpi-Hyövälti, Oksa (bib0020) 2010; 10 Wu, Chen, Chen, Lin, Tseng (bib0150) 2010; 287 She, Xiong, Hazra, Tsukamoto (bib0098) 2005; 280 Sun, Chen, Wen, Sun, An, Pang (bib0153) 2018; 136 Weltman, Farrell, Liddle (bib0039) 1996; 111 Wang, Dong, Liu, Ni, Sai, You (bib0135) 2020; 131 Tian, Wong, Wong, Yang, Sun, Shen (bib0111) 2015; 75 Akcora, Storm, Bansal (bib0144) 2018; 1864 Argo, Caldwell (bib0012) 2009; 13 Kitamoto, Kitamoto, Yoneda, Hyogo, Ochi, Nakamura (bib0011) 2013; 132 Postic, Girard (bib0034) 2008; 118 Grant, Thorleifsson, Reynisdottir, Benediktsson, Manolescu, Sainz (bib0084) 2006; 38 Tian, Zhang, Li, Xie (bib0129) 2014; 9 Zhang, Haughey, Wang, Blease, Kapoun, Couto (bib0139) 2020; 15 Cheng, She, Han, Wang, Xiong, Asahina (bib0091) 2008; 294 Byrne, Targher (bib0007) 2015; 62 Sekine, Lan, Bedolli, Feng, Hebrok (bib0073) 2006; 43 Shan, Zhang, Bao, Cassell, Zheng (bib0123) 2012; 79 Polosukhina, Love, Moses, Lee, Zent, Clark (bib0126) 2017; 25 Li, Xi, Tinsley, Gurpinar, Gary, Zhu (bib0125) 2013; 12 El-Derany, El-Demerdash (bib0128) 2020; 177 Friedman, Neuschwander-Tetri, Rinella, Sanyal (bib0018) 2018; 24 Chalasani, Deeg, Crabb (bib0036) 2004; 99 Kim, Park, Lee, Lee, Jeon, Kim (bib0014) 2009; 337 Ezhilarasan (bib0052) 2020; 245 Stienstra, Saudale, Duval, Keshtkar, Groener, van Rooijen (bib0047) 2010; 51 Boschert, van Dinther, Weidauer, van Pee, Muth, Ten Dijke (bib0120) 2013; 8 Aberle, Bauer, Stappert, Kispert, Kemler (bib0061) 1997; 16 Tan, Behari, Cieply, Michalopoulos, Monga (bib0068) 2006; 131 Hsu, Wang, Kota, Yu, Costinean, Kutay (bib0112) 2012; 122 Monga, Hout, Baun, Micsenyi, Muller, Tummalapalli (bib0067) 2005; 167 Buzzetti, Pinzani, Tsochatzis (bib0027) 2016; 65 Sahin, Trautwein, Wasmuth (bib0053) 2010; 7 Zhang, Song, Yang, Dai, Li, Wang (bib0124) 2015; 48 Stemmer, Benjaminov, Medalia, Ciuraru, Silverman, Bar-Yehuda (bib0131) 2013; 18 Jang, Hong, Kim, Lee, Park, Lee (bib0142) 2015; 75 Gross, Wan, Birnbaum (bib0083) 2009; 9 Rowell, Anstee (bib0001) 2015; 15 Younossi, Koenig, Abdelatif, Fazel, Henry, Wymer (bib0005) 2016; 64 Anstee, Targher, Day (bib0022) 2013; 10 Tao, Zhang, Zeng, Shulman, Jin (bib0137) 2014; 20 Register, Hruska, Divers, Bowden, Palmer, Carr (bib0081) 2013; 98 Lade, Noon, Friedman (bib0057) 2014; 26 Sheehan, Hitchcock, Sibley (bib0134) 1999; 12 Son, Kojima, Decaens, Yamaguchi, Ito, Imamura (bib0075) 2009; 131 Feldstein, Werneburg, Canbay, Guicciardi, Bronk, Rydzewski (bib0029) 2004; 40 Jia, Yuan, Xu, Li, Yang, Jiang (bib0152) 2016; 13 Liu, Singh, Choi, Lee, Keramati, Samuel (bib0079) 2012; 287 Le Roy, Llopis, Lepage, Bruneau, Rabot, Bevilacqua (bib0016) 2013; 62 Neuschwander-Tetri (bib0035) 2017; 15 Sivaramakrishnan, Shilpa, Praveen Kumar, Niranjali Devaraj (bib0147) 2008; 171 Breitkopf, Godoy, Ciuclan, Singer, Dooley (bib0051) 2006; 44 Saraswati, Alfaro, Thorne, Atkinson, Lee, Young (bib0127) 2010; 5 Huang (bib0017) 2009; 2 Bendell, Eckhardt, Hochster, Morris, Strickler, Kapoun (bib0140) 2016; 69 Wu, Wang, Qian, Qiao, Zou, Chen (bib0114) 2017; 37 Samuel, Liu, Qu, Elder, Bilz, Befroy (bib0088) 2004; 279 Xiao, Xing, Liu, Lv, Wang, Ling (bib0107) 2018; 8 Hotamisligil (bib0040) 2006; 444 Kok, Wong, Wu, Chan, Kwok, Fung (bib0146) 2000; 67 Kaur, Mani, Cros, Scoazec, Chemin, Hainaut (bib0108) 2012; 33 Alcolado, Arthur, Iredale (bib0059) 1997; 92 Williams, Iredale (bib0058) 1998; 74 Barrott, Cash, Smith, Barrow, Murtaugh (bib0064) 2011; 108 Lee, Friedman (bib0055) 2011; 25 Lindenmeyer, McCullough (bib0006) 2018; 22 Welsh, Karpen, Vos (bib0024) 2013; 162 Cadoret, Ovejero, Terris, Souil, Lévy, Lamers (bib0072) 2002; 21 Jiang, Parsons, Stefanovic (bib0099) 2006; 45 Romeo, Kozlitina, Xing, Pertsemlidis, Cox, Pennacchio (bib0010) 2008; 40 Zhang, Yuan, He, Lei, Wang (bib0049) 2016; 22 Ratziu, Bellentani, Cortez-Pinto, Day, Marchesini (bib0033) 2010; 53 Gurney, Axelrod, Bond, Cain, Chartier, Donigan (bib0118) 2012; 109 Myung, Yoon, Gwak, Kim, Lee, Kim (bib0092) 2007; 581 Xavier, Melikova, Chuman, Üren, Baljinnyam, Rubin (bib0119) 2014; 26 Watanabe, Sohail, Gomes, Hashmi, Nagata, Sutterwala (bib0045) 2009; 296 Klein, Demory, Peyre, Kroll, Augustin, Helfrich (bib0103) 2008; 47 Guo, Zhou, Yang, Shao (bib0155) 2019; 110 Li, Shan, Chang, Kim, Bao, Lee (bib0085) 2012; 109 Bugianesi, Moscatiello, Ciaravella, Marchesini (bib0028) 2010; 16 Ahmed, Byrne (bib0015) 2010; 16 Pessayre, Fromenty (bib0037) 2005; 42 Rock, Latz, Ontiveros, Kono (bib0046) 2010; 28 Jia, Yang, Liu, Herman, Lu, Guo (bib0109) 2010; 5 MadanKumar, NaveenKumar, Manikandan, Devaraj, NiranjaliDevaraj (bib0149) 2014; 277 Guilherme, Virbasius, Puri, Czech (bib0030) 2008; 9 Begriche, Igoudjil, Pessayre, Fromenty (bib0038) 2006; 6 Miura, Kodama, Inokuchi, Schnabl, Aoyama, Ohnishi (bib0048) 2010; 139 Fang, Chen, Wang, Liang (bib0025) 2018; 24 Ouchi, Higuchi, Ohashi, Oshima, Gokce, Shibata (bib0089) 2010; 329 El-Ashmawy, Al-Ashmawy, Fakher, Khedr (bib0138) 2020; 136 Wang, Song, Srivastava, Dong, Go, Li (bib0086) 2015; 29 Shan, Shi, Wang, Zheng (bib0121) 2005; 44 Tomita, Tamiya, Ando, Ohsumi, Chiyo, Mizutani (bib0042) 2006; 55 Zhao, Ye, Gao, Li (bib0154) 2019; 39 Grandy, Shan, Zhang, Rao, Akunuru, Li (bib0122) 2009; 284 Go (bib0080) 2015; 7 Toshikuni, Tsutsumi, Arisawa (bib0021) 2014; 20 Li, Zhu, Li, Wu, Gao (bib0095) 2014; 8 Monga, Pediaditakis, Mule, Stolz, Michalopoulos (bib0069) 2001; 33 Cai, Yuan, Frantz, Melendez, Hansen, Lee (bib0041) 2005; 11 Käräjämäki, Bloigu, Kauma, Kesäniemi, Koivurova, Perkiömäki (bib0019) 2017; 66 Zhang, Liu, Yu, Li, Li (bib0151) 2018; 37 Katanaev (bib0063) 2010; 75 Pikarsky, Porat, Stein, Abramovitch, Amit, Kasem (bib0044) 2004; 431 Tanaka, Leung, Kenny, Au-Young, Prindiville, Coppel (bib0090) 2001; 17 Jou, Choi, Diehl (bib0031) 2008; 28 Carpino, Nobili, Renzi, De Stefanis, Stronati, Franchitto (bib0105) 2016; 11 Oh, Talukdar, Bae, Imamura, Morinaga, Fan (bib0136) 2010; 142 Chang, Ryu, Sung, Woo, Cho, Yoo (bib0013) 2009; 58 Li, Gong, Wang, Liu, Chu, Gui (bib0104) 2021; 8 Fonseca, Predes, Cerqueira, Reis, Amado, Cayres (bib0116) 2015; 10 Li, Yuan, Weaver, Mao, Farr, Sussman (bib0065) 1999; 18 Fang, Zhu, Neuenschwander, Specker, Wulf-Goldenberg, Weis (bib0143) 2016; 76 Ramachandran, Pellicoro, Vernon, Boulter, Aucott, Ali (bib0054) 2012; 109 Cheng, Lau, Chen, Kondo, Li, Feng (bib0110) 2011; 71 Zeng, Awan, Otruba, Muller, Apte, Tan (bib0102) 2007; 45 Tran, Zheng (bib0115) 2017; 26 Gougelet, Torre, Veber, Sartor, Bachelot, Denechaud (bib0071) 2014; 59 Monga (bib0060) 2015; 148 Anstee, McPherson, Day (bib0002) 2011; 343 Ezhilarasan (bib0050) 2022; 237 Xiong, Hu, Jian, Wang, Jiang, Li (bib0093) 2012; 18 Argo, Northup, Al-Osaimi, Caldwell (bib0008) 2009; 51 Day, James (bib0026) 1998; 114 Zhou, Song, Peng, Zhou, Wei, Zhou (bib0078) 2016; 7 Fishman, Cohen, Itzhak, Amer, Salhab, Barer (bib0132) 2019; 44 Haukeland, Damås, Konopski, Løberg, Haaland, Goverud (bib0043) 2006; 44 Barker, Clevers (bib0106) 2006; 5 Zhao (10.1016/j.hbpd.2022.10.003_bib0154) 2019; 39 Lade (10.1016/j.hbpd.2022.10.003_bib0057) 2014; 26 Klein (10.1016/j.hbpd.2022.10.003_bib0103) 2008; 47 Fang (10.1016/j.hbpd.2022.10.003_bib0148) 2003; 74 Wang (10.1016/j.hbpd.2022.10.003_bib0086) 2015; 29 Barker (10.1016/j.hbpd.2022.10.003_bib0106) 2006; 5 Liu (10.1016/j.hbpd.2022.10.003_bib0079) 2012; 287 Stienstra (10.1016/j.hbpd.2022.10.003_bib0047) 2010; 51 Pinson (10.1016/j.hbpd.2022.10.003_bib0062) 2000; 407 Cohen (10.1016/j.hbpd.2022.10.003_bib0130) 2011; 226 Friedman (10.1016/j.hbpd.2022.10.003_bib0018) 2018; 24 Boschert (10.1016/j.hbpd.2022.10.003_bib0120) 2013; 8 Ahmed (10.1016/j.hbpd.2022.10.003_bib0015) 2010; 16 Ratziu (10.1016/j.hbpd.2022.10.003_bib0033) 2010; 53 Gougelet (10.1016/j.hbpd.2022.10.003_bib0071) 2014; 59 Jia (10.1016/j.hbpd.2022.10.003_bib0109) 2010; 5 Argo (10.1016/j.hbpd.2022.10.003_bib0008) 2009; 51 Argo (10.1016/j.hbpd.2022.10.003_bib0012) 2009; 13 Kanazawa (10.1016/j.hbpd.2022.10.003_bib0145) 2005; 330 Bendell (10.1016/j.hbpd.2022.10.003_bib0140) 2016; 69 Sun (10.1016/j.hbpd.2022.10.003_bib0153) 2018; 136 Miura (10.1016/j.hbpd.2022.10.003_bib0048) 2010; 139 Hotamisligil (10.1016/j.hbpd.2022.10.003_bib0040) 2006; 444 Kotronen (10.1016/j.hbpd.2022.10.003_bib0020) 2010; 10 Liu (10.1016/j.hbpd.2022.10.003_bib0082) 2011; 4 Fang (10.1016/j.hbpd.2022.10.003_bib0143) 2016; 76 Xiong (10.1016/j.hbpd.2022.10.003_bib0093) 2012; 18 Jiang (10.1016/j.hbpd.2022.10.003_bib0099) 2006; 45 Zhang (10.1016/j.hbpd.2022.10.003_bib0151) 2018; 37 Le Roy (10.1016/j.hbpd.2022.10.003_bib0016) 2013; 62 Rowell (10.1016/j.hbpd.2022.10.003_bib0001) 2015; 15 Chang (10.1016/j.hbpd.2022.10.003_bib0013) 2009; 58 Brunt (10.1016/j.hbpd.2022.10.003_bib0003) 1999; 94 Neuschwander-Tetri (10.1016/j.hbpd.2022.10.003_bib0035) 2017; 15 Monga (10.1016/j.hbpd.2022.10.003_bib0067) 2005; 167 She (10.1016/j.hbpd.2022.10.003_bib0098) 2005; 280 Fonseca (10.1016/j.hbpd.2022.10.003_bib0116) 2015; 10 Aberle (10.1016/j.hbpd.2022.10.003_bib0061) 1997; 16 Madan (10.1016/j.hbpd.2022.10.003_bib0141) 2016; 35 MadanKumar (10.1016/j.hbpd.2022.10.003_bib0149) 2014; 277 Younossi (10.1016/j.hbpd.2022.10.003_bib0005) 2016; 64 Monga (10.1016/j.hbpd.2022.10.003_bib0060) 2015; 148 Jou (10.1016/j.hbpd.2022.10.003_bib0031) 2008; 28 Ramachandran (10.1016/j.hbpd.2022.10.003_bib0054) 2012; 109 Micsenyi (10.1016/j.hbpd.2022.10.003_bib0066) 2004; 126 Wang (10.1016/j.hbpd.2022.10.003_bib0077) 2019; 44 Käräjämäki (10.1016/j.hbpd.2022.10.003_bib0019) 2017; 66 Pessayre (10.1016/j.hbpd.2022.10.003_bib0037) 2005; 42 Welsh (10.1016/j.hbpd.2022.10.003_bib0024) 2013; 162 Li (10.1016/j.hbpd.2022.10.003_bib0125) 2013; 12 Tao (10.1016/j.hbpd.2022.10.003_bib0137) 2014; 20 Pikarsky (10.1016/j.hbpd.2022.10.003_bib0044) 2004; 431 Day (10.1016/j.hbpd.2022.10.003_bib0026) 1998; 114 Ezhilarasan (10.1016/j.hbpd.2022.10.003_bib0052) 2020; 245 Xavier (10.1016/j.hbpd.2022.10.003_bib0119) 2014; 26 Behari (10.1016/j.hbpd.2022.10.003_bib0087) 2010; 176 Byrne (10.1016/j.hbpd.2022.10.003_bib0007) 2015; 62 Buzzetti (10.1016/j.hbpd.2022.10.003_bib0027) 2016; 65 Zhang (10.1016/j.hbpd.2022.10.003_bib0100) 2013; 374 Li (10.1016/j.hbpd.2022.10.003_bib0085) 2012; 109 Gross (10.1016/j.hbpd.2022.10.003_bib0083) 2009; 9 Wang (10.1016/j.hbpd.2022.10.003_bib0135) 2020; 131 Kim (10.1016/j.hbpd.2022.10.003_bib0014) 2009; 337 Sivaramakrishnan (10.1016/j.hbpd.2022.10.003_bib0147) 2008; 171 Zhang (10.1016/j.hbpd.2022.10.003_bib0124) 2015; 48 Alcolado (10.1016/j.hbpd.2022.10.003_bib0059) 1997; 92 Grant (10.1016/j.hbpd.2022.10.003_bib0084) 2006; 38 Breitkopf (10.1016/j.hbpd.2022.10.003_bib0051) 2006; 44 Ouchi (10.1016/j.hbpd.2022.10.003_bib0089) 2010; 329 El-Derany (10.1016/j.hbpd.2022.10.003_bib0128) 2020; 177 Williams (10.1016/j.hbpd.2022.10.003_bib0058) 1998; 74 Tan (10.1016/j.hbpd.2022.10.003_bib0068) 2006; 131 Zhou (10.1016/j.hbpd.2022.10.003_bib0078) 2016; 7 Bugianesi (10.1016/j.hbpd.2022.10.003_bib0028) 2010; 16 Roskams (10.1016/j.hbpd.2022.10.003_bib0032) 2003; 163 Guilherme (10.1016/j.hbpd.2022.10.003_bib0030) 2008; 9 Toshikuni (10.1016/j.hbpd.2022.10.003_bib0021) 2014; 20 Nejak-Bowen (10.1016/j.hbpd.2022.10.003_bib0070) 2011; 21 Tian (10.1016/j.hbpd.2022.10.003_bib0129) 2014; 9 Wu (10.1016/j.hbpd.2022.10.003_bib0150) 2010; 287 Aragno (10.1016/j.hbpd.2022.10.003_bib0023) 2009; 47 Li (10.1016/j.hbpd.2022.10.003_bib0065) 1999; 18 Ross (10.1016/j.hbpd.2022.10.003_bib0096) 2000; 289 Shan (10.1016/j.hbpd.2022.10.003_bib0123) 2012; 79 Cadoret (10.1016/j.hbpd.2022.10.003_bib0072) 2002; 21 Cheng (10.1016/j.hbpd.2022.10.003_bib0091) 2008; 294 Romeo (10.1016/j.hbpd.2022.10.003_bib0010) 2008; 40 Li (10.1016/j.hbpd.2022.10.003_bib0095) 2014; 8 Wu (10.1016/j.hbpd.2022.10.003_bib0114) 2017; 37 Postic (10.1016/j.hbpd.2022.10.003_bib0034) 2008; 118 Jang (10.1016/j.hbpd.2022.10.003_bib0142) 2015; 75 Fako (10.1016/j.hbpd.2022.10.003_bib0133) 2016; 12 Rock (10.1016/j.hbpd.2022.10.003_bib0046) 2010; 28 Go (10.1016/j.hbpd.2022.10.003_bib0080) 2015; 7 Zhang (10.1016/j.hbpd.2022.10.003_bib0139) 2020; 15 Myung (10.1016/j.hbpd.2022.10.003_bib0092) 2007; 581 Fishman (10.1016/j.hbpd.2022.10.003_bib0132) 2019; 44 Cai (10.1016/j.hbpd.2022.10.003_bib0041) 2005; 11 Saraswati (10.1016/j.hbpd.2022.10.003_bib0127) 2010; 5 Oh (10.1016/j.hbpd.2022.10.003_bib0136) 2010; 142 Lee (10.1016/j.hbpd.2022.10.003_bib0055) 2011; 25 Anstee (10.1016/j.hbpd.2022.10.003_bib0002) 2011; 343 Son (10.1016/j.hbpd.2022.10.003_bib0075) 2009; 131 Zeng (10.1016/j.hbpd.2022.10.003_bib0102) 2007; 45 Huang (10.1016/j.hbpd.2022.10.003_bib0017) 2009; 2 El-Ashmawy (10.1016/j.hbpd.2022.10.003_bib0138) 2020; 136 Sahin (10.1016/j.hbpd.2022.10.003_bib0053) 2010; 7 Kim (10.1016/j.hbpd.2022.10.003_bib0009) 2015; 31 Hsu (10.1016/j.hbpd.2022.10.003_bib0112) 2012; 122 Ezhilarasan (10.1016/j.hbpd.2022.10.003_bib0050) 2022; 237 Kaur (10.1016/j.hbpd.2022.10.003_bib0108) 2012; 33 Kok (10.1016/j.hbpd.2022.10.003_bib0146) 2000; 67 Weltman (10.1016/j.hbpd.2022.10.003_bib0039) 1996; 111 Gurney (10.1016/j.hbpd.2022.10.003_bib0118) 2012; 109 Barrott (10.1016/j.hbpd.2022.10.003_bib0064) 2011; 108 Du (10.1016/j.hbpd.2022.10.003_bib0101) 2020; 2020 Feldstein (10.1016/j.hbpd.2022.10.003_bib0029) 2004; 40 Monga (10.1016/j.hbpd.2022.10.003_bib0069) 2001; 33 Li (10.1016/j.hbpd.2022.10.003_bib0104) 2021; 8 Lindenmeyer (10.1016/j.hbpd.2022.10.003_bib0006) 2018; 22 Katanaev (10.1016/j.hbpd.2022.10.003_bib0063) 2010; 75 Sekine (10.1016/j.hbpd.2022.10.003_bib0073) 2006; 43 Samuel (10.1016/j.hbpd.2022.10.003_bib0088) 2004; 279 Haukeland (10.1016/j.hbpd.2022.10.003_bib0043) 2006; 44 Ge (10.1016/j.hbpd.2022.10.003_bib0094) 2014; 9 Carpino (10.1016/j.hbpd.2022.10.003_bib0105) 2016; 11 Friedman (10.1016/j.hbpd.2022.10.003_bib0056) 2008; 134 Tran (10.1016/j.hbpd.2022.10.003_bib0115) 2017; 26 Watanabe (10.1016/j.hbpd.2022.10.003_bib0045) 2009; 296 Polosukhina (10.1016/j.hbpd.2022.10.003_bib0126) 2017; 25 Stemmer (10.1016/j.hbpd.2022.10.003_bib0131) 2013; 18 Sheehan (10.1016/j.hbpd.2022.10.003_bib0134) 1999; 12 Tian (10.1016/j.hbpd.2022.10.003_bib0111) 2015; 75 Anstee (10.1016/j.hbpd.2022.10.003_bib0022) 2013; 10 Xiao (10.1016/j.hbpd.2022.10.003_bib0107) 2018; 8 Kitamoto (10.1016/j.hbpd.2022.10.003_bib0011) 2013; 132 de la Roche (10.1016/j.hbpd.2022.10.003_bib0117) 2012; 3 Shan (10.1016/j.hbpd.2022.10.003_bib0121) 2005; 44 Begriche (10.1016/j.hbpd.2022.10.003_bib0038) 2006; 6 Younossi (10.1016/j.hbpd.2022.10.003_bib0004) 2018; 15 Tomita (10.1016/j.hbpd.2022.10.003_bib0042) 2006; 55 Yeh (10.1016/j.hbpd.2022.10.003_bib0074) 2010; 52 Register (10.1016/j.hbpd.2022.10.003_bib0081) 2013; 98 Cheng (10.1016/j.hbpd.2022.10.003_bib0110) 2011; 71 Guo (10.1016/j.hbpd.2022.10.003_bib0155) 2019; 110 Chalasani (10.1016/j.hbpd.2022.10.003_bib0036) 2004; 99 Hazra (10.1016/j.hbpd.2022.10.003_bib0097) 2004; 279 Gougelet (10.1016/j.hbpd.2022.10.003_bib0113) 2016; 65 Grandy (10.1016/j.hbpd.2022.10.003_bib0122) 2009; 284 Tanaka (10.1016/j.hbpd.2022.10.003_bib0090) 2001; 17 Ackers (10.1016/j.hbpd.2022.10.003_bib0076) 2018; 15 Zhang (10.1016/j.hbpd.2022.10.003_bib0049) 2016; 22 Jia (10.1016/j.hbpd.2022.10.003_bib0152) 2016; 13 Akcora (10.1016/j.hbpd.2022.10.003_bib0144) 2018; 1864 Fang (10.1016/j.hbpd.2022.10.003_bib0025) 2018; 24 |
References_xml | – volume: 108 start-page: 12752 year: 2011 end-page: 12757 ident: bib0064 article-title: Deletion of mouse Porcn blocks Wnt ligand secretion and reveals an ectodermal etiology of human focal dermal hypoplasia/Goltz syndrome publication-title: Proc Natl Acad Sci U S A – volume: 279 start-page: 11392 year: 2004 end-page: 11401 ident: bib0097 article-title: Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells publication-title: J Biol Chem – volume: 10 start-page: 237 year: 2010 ident: bib0020 article-title: Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey publication-title: BMC Public Health – volume: 76 start-page: 891 year: 2016 end-page: 901 ident: bib0143 article-title: A small-molecule antagonist of the β-catenin/TCF4 interaction blocks the self-renewal of cancer stem cells and suppresses tumorigenesis publication-title: Cancer Res – volume: 79 start-page: 376 year: 2012 end-page: 383 ident: bib0123 article-title: Synthesis of potent dishevelled PDZ domain inhibitors guided by virtual screening and NMR studies publication-title: Chem Biol Drug Des – volume: 20 start-page: 1263 year: 2014 end-page: 1269 ident: bib0137 article-title: Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice publication-title: Nat Med – volume: 26 start-page: 94 year: 2014 end-page: 101 ident: bib0119 article-title: Secreted Frizzled-related protein potentiation versus inhibition of Wnt3a/β-catenin signaling publication-title: Cell Signal – volume: 12 start-page: 1848 year: 2013 end-page: 1859 ident: bib0125 article-title: Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling publication-title: Mol Cancer Ther – volume: 9 start-page: 367 year: 2008 end-page: 377 ident: bib0030 article-title: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes publication-title: Nat Rev Mol Cell Biol – volume: 109 start-page: 11402 year: 2012 end-page: 11407 ident: bib0085 article-title: Chemical and genetic evidence for the involvement of Wnt antagonist Dickkopf2 in regulation of glucose metabolism publication-title: Proc Natl Acad Sci U S A – volume: 3 start-page: 680 year: 2012 ident: bib0117 article-title: An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid publication-title: Nat Commun – volume: 287 start-page: 187 year: 2010 end-page: 195 ident: bib0150 article-title: Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice publication-title: Cancer Lett – volume: 177 year: 2020 ident: bib0128 article-title: Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk publication-title: Biochem Pharmacol – volume: 8 start-page: 282 year: 2014 end-page: 291 ident: bib0095 article-title: Mest attenuates CCl4-induced liver fibrosis in rats by inhibiting the Wnt/β-catenin signaling pathway publication-title: Gut Liver – volume: 17 start-page: 89 year: 2001 end-page: 98 ident: bib0090 article-title: Genomic analysis of differentially expressed genes in liver and biliary epithelial cells of patients with primary biliary cirrhosis publication-title: J Autoimmun – volume: 43 start-page: 817 year: 2006 end-page: 825 ident: bib0073 article-title: Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice publication-title: Hepatology – volume: 126 start-page: 1134 year: 2004 end-page: 1146 ident: bib0066 article-title: Beta-catenin is temporally regulated during normal liver development publication-title: Gastroenterology – volume: 374 start-page: 13 year: 2013 end-page: 20 ident: bib0100 article-title: Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through promoting the ROS production publication-title: Mol Cell Biochem – volume: 12 start-page: 768 year: 2016 end-page: 775 ident: bib0133 article-title: Inhibition of wnt/β-catenin signaling in hepatocellular carcinoma by an antipsychotic drug pimozide publication-title: Int J Biol Sci – volume: 37 start-page: 7 year: 2018 ident: bib0151 article-title: The plant alkaloid tetrandrine inhibits metastasis via autophagy-dependent Wnt/β-catenin and metastatic tumor antigen 1 signaling in human liver cancer cells publication-title: J Exp Clin Cancer Res – volume: 16 start-page: 1941 year: 2010 end-page: 1951 ident: bib0028 article-title: Insulin resistance in nonalcoholic fatty liver disease publication-title: Curr Pharm Des – volume: 109 start-page: E3186 year: 2012 end-page: E3195 ident: bib0054 article-title: Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis publication-title: Proc Natl Acad Sci U S A – volume: 62 start-page: 1787 year: 2013 end-page: 1794 ident: bib0016 article-title: Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice publication-title: Gut – volume: 38 start-page: 320 year: 2006 end-page: 323 ident: bib0084 article-title: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes publication-title: Nat Genet – volume: 237 start-page: 436 year: 2022 end-page: 449 ident: bib0050 article-title: Hepatic stellate cells in the injured liver: perspectives beyond hepatic fibrosis publication-title: J Cell Physiol – volume: 114 start-page: 842 year: 1998 end-page: 845 ident: bib0026 article-title: Steatohepatitis: a tale of two "hits"? publication-title: Gastroenterology – volume: 9 start-page: 208 year: 2009 end-page: 214 ident: bib0083 article-title: The role of FOXO in the regulation of metabolism publication-title: Curr Diab Rep – volume: 37 start-page: 62 year: 2017 end-page: 73 ident: bib0114 article-title: Sirt1 suppresses Wnt/βCatenin signaling in liver cancer cells by targeting βCatenin in a PKAα-dependent manner publication-title: Cell Signal – volume: 444 start-page: 860 year: 2006 end-page: 867 ident: bib0040 article-title: Inflammation and metabolic disorders publication-title: Nature – volume: 40 start-page: 185 year: 2004 end-page: 194 ident: bib0029 article-title: Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway publication-title: Hepatology – volume: 118 start-page: 829 year: 2008 end-page: 838 ident: bib0034 article-title: Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice publication-title: J Clin Invest – volume: 7 start-page: 4453 year: 2015 end-page: 4464 ident: bib0080 article-title: Low-density lipoprotein receptor-related protein 6 (LRP6) is a novel nutritional therapeutic target for hyperlipidemia, non-alcoholic fatty liver disease, and atherosclerosis publication-title: Nutrients – volume: 167 start-page: 1279 year: 2005 end-page: 1292 ident: bib0067 article-title: Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors publication-title: Am J Pathol – volume: 64 start-page: 73 year: 2016 end-page: 84 ident: bib0005 article-title: Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes publication-title: Hepatology – volume: 20 start-page: 8393 year: 2014 end-page: 8406 ident: bib0021 article-title: Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease publication-title: World J Gastroenterol – volume: 31 start-page: 184 year: 2015 end-page: 191 ident: bib0009 article-title: Aging and liver disease publication-title: Curr Opin Gastroenterol – volume: 51 start-page: 511 year: 2010 end-page: 522 ident: bib0047 article-title: Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity publication-title: Hepatology – volume: 337 start-page: 98 year: 2009 end-page: 102 ident: bib0014 article-title: Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans publication-title: Am J Med Sci – volume: 15 year: 2020 ident: bib0139 article-title: Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs publication-title: PLoS One – volume: 5 start-page: e15521 year: 2010 ident: bib0127 article-title: Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling publication-title: PLoS One – volume: 131 year: 2020 ident: bib0135 article-title: Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways publication-title: Biomed Pharmacother – volume: 15 start-page: s77 year: 2015 end-page: s82 ident: bib0001 article-title: An overview of the genetics, mechanisms and management of NAFLD and ALD publication-title: Clin Med (Lond) – volume: 65 start-page: 1038 year: 2016 end-page: 1048 ident: bib0027 article-title: The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) publication-title: Metabolism – volume: 33 start-page: 325 year: 2012 end-page: 336 ident: bib0108 article-title: Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma publication-title: Tumour Biol – volume: 40 start-page: 1461 year: 2008 end-page: 1465 ident: bib0010 article-title: Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease publication-title: Nat Genet – volume: 581 start-page: 2954 year: 2007 end-page: 2958 ident: bib0092 article-title: Wnt signaling enhances the activation and survival of human hepatic stellate cells publication-title: FEBS Lett – volume: 45 start-page: 401 year: 2006 end-page: 409 ident: bib0099 article-title: Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation publication-title: J Hepatol – volume: 296 start-page: G1248 year: 2009 end-page: G1257 ident: bib0045 article-title: Inflammasome-mediated regulation of hepatic stellate cells publication-title: Am J Physiol Gastrointest Liver Physiol – volume: 280 start-page: 4959 year: 2005 end-page: 4967 ident: bib0098 article-title: Adipogenic transcriptional regulation of hepatic stellate cells publication-title: J Biol Chem – volume: 171 start-page: 79 year: 2008 end-page: 88 ident: bib0147 article-title: Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-Morin publication-title: Chem Biol Interact – volume: 66 start-page: 55 year: 2017 end-page: 63 ident: bib0019 article-title: Non-alcoholic fatty liver disease with and without metabolic syndrome: different long-term outcomes publication-title: Metabolism – volume: 431 start-page: 461 year: 2004 end-page: 466 ident: bib0044 article-title: NF-kappaB functions as a tumour promoter in inflammation-associated cancer publication-title: Nature – volume: 136 start-page: 133 year: 2018 end-page: 141 ident: bib0153 article-title: Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing NF-κB signaling and Wnt/β-catenin signaling publication-title: J Pharmacol Sci – volume: 4 start-page: ra6 year: 2011 ident: bib0082 article-title: Wnt signaling regulates hepatic metabolism publication-title: Sci Signal – volume: 10 start-page: 330 year: 2013 end-page: 344 ident: bib0022 article-title: Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis publication-title: Nat Rev Gastroenterol Hepatol – volume: 67 start-page: 91 year: 2000 end-page: 99 ident: bib0146 article-title: Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs publication-title: Life Sci – volume: 21 start-page: 44 year: 2011 end-page: 58 ident: bib0070 article-title: Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad publication-title: Semin Cancer Biol – volume: 16 start-page: 3797 year: 1997 end-page: 3804 ident: bib0061 article-title: Beta-catenin is a target for the ubiquitin-proteasome pathway publication-title: EMBO J – volume: 75 start-page: 1691 year: 2015 end-page: 1702 ident: bib0142 article-title: Wnt/β-catenin small-molecule inhibitor CWP232228 preferentially inhibits the growth of breast cancer stem-like cells publication-title: Cancer Res – volume: 12 start-page: 40 year: 1999 end-page: 79 ident: bib0134 article-title: Current and emerging azole antifungal agents publication-title: Clin Microbiol Rev – volume: 131 start-page: 1561 year: 2006 end-page: 1572 ident: bib0068 article-title: Conditional deletion of beta-catenin reveals its role in liver growth and regeneration publication-title: Gastroenterology – volume: 44 start-page: 57 year: 2006 end-page: 66 ident: bib0051 article-title: TGF-beta/Smad signaling in the injured liver publication-title: Z Gastroenterol – volume: 28 start-page: 321 year: 2010 end-page: 342 ident: bib0046 article-title: The sterile inflammatory response publication-title: Annu Rev Immunol – volume: 51 start-page: 371 year: 2009 end-page: 379 ident: bib0008 article-title: Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis publication-title: J Hepatol – volume: 65 start-page: 1024 year: 2016 end-page: 1034 ident: bib0113 article-title: Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations publication-title: Gut – volume: 25 start-page: 195 year: 2011 end-page: 206 ident: bib0055 article-title: Mechanisms of hepatic fibrogenesis publication-title: Best Pract Res Clin Gastroenterol – volume: 39 start-page: 913 year: 2019 end-page: 919 ident: bib0154 article-title: Diwu Yanggan modulates the Wnt/β-catenin pathway and inhibits liver carcinogenesis signaling in 2-AAF/PH model rats publication-title: Curr Med Sci – volume: 69 start-page: S29 year: 2016 end-page: S30 ident: bib0140 article-title: Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC) publication-title: Eur J Cancer – volume: 329 start-page: 454 year: 2010 end-page: 457 ident: bib0089 article-title: Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity publication-title: Science – volume: 8 year: 2021 ident: bib0104 article-title: Sirt1 promotes the restoration of hepatic progenitor cell (HPC)-mediated liver fatty injury in NAFLD through activating the Wnt/β-catenin signal pathway publication-title: Front Nutr – volume: 11 year: 2016 ident: bib0105 article-title: Macrophage activation in pediatric nonalcoholic fatty liver disease (NAFLD) correlates with hepatic progenitor cell response via Wnt3a pathway publication-title: PLoS One – volume: 94 start-page: 2467 year: 1999 end-page: 2474 ident: bib0003 article-title: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions publication-title: Am J Gastroenterol – volume: 284 start-page: 16256 year: 2009 end-page: 16263 ident: bib0122 article-title: Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled publication-title: J Biol Chem – volume: 9 start-page: e83819 year: 2014 ident: bib0129 article-title: Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression publication-title: PLoS One – volume: 24 start-page: 908 year: 2018 end-page: 922 ident: bib0018 article-title: Mechanisms of NAFLD development and therapeutic strategies publication-title: Nat Med – volume: 131 start-page: 411 year: 2009 end-page: 424 ident: bib0075 article-title: Knockdown of tight junction protein claudin-2 prevents bile canalicular formation in WIF-B9 cells publication-title: Histochem Cell Biol – volume: 18 start-page: 1745 year: 2012 end-page: 1752 ident: bib0093 article-title: Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays publication-title: World J Gastroenterol – volume: 99 start-page: 1497 year: 2004 end-page: 1502 ident: bib0036 article-title: Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis publication-title: Am J Gastroenterol – volume: 9 start-page: 2145 year: 2014 end-page: 2151 ident: bib0094 article-title: Zhu L. β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation publication-title: Mol Med Rep – volume: 289 start-page: 950 year: 2000 end-page: 953 ident: bib0096 article-title: Inhibition of adipogenesis by Wnt signaling publication-title: Science – volume: 22 start-page: 11 year: 2018 end-page: 21 ident: bib0006 article-title: The natural history of nonalcoholic fatty liver disease-an evolving view publication-title: Clin Liver Dis – volume: 33 start-page: 1098 year: 2001 end-page: 1109 ident: bib0069 article-title: Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration publication-title: Hepatology – volume: 110 start-page: 371 year: 2019 end-page: 379 ident: bib0155 article-title: Dendrobium candidum extract inhibits proliferation and induces apoptosis of liver cancer cells by inactivating Wnt/β-catenin signaling pathway publication-title: Biomed Pharmacother – volume: 132 start-page: 783 year: 2013 end-page: 792 ident: bib0011 article-title: Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan publication-title: Hum Genet – volume: 74 start-page: 193 year: 1998 end-page: 202 ident: bib0058 article-title: Liver cirrhosis publication-title: Postgrad Med J – volume: 136 year: 2020 ident: bib0138 article-title: The role of WNT/β-catenin signaling pathway and glutamine metabolism in the pathogenesis of CCl4-induced liver fibrosis: repositioning of niclosamide and concerns about lithium publication-title: Cytokine – volume: 74 start-page: 743 year: 2003 end-page: 756 ident: bib0148 article-title: Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock publication-title: Life Sci – volume: 10 year: 2015 ident: bib0116 article-title: Derricin and derricidin inhibit Wnt/β-catenin signaling and suppress colon cancer cell growth in vitro publication-title: PLoS One – volume: 8 start-page: 575 year: 2018 end-page: 586 ident: bib0107 article-title: Garlic-derived compound S-allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway publication-title: Acta Pharm Sin B – volume: 47 start-page: 1018 year: 2008 end-page: 1031 ident: bib0103 article-title: Wnt2 acts as a cell type-specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway publication-title: Hepatology – volume: 44 start-page: 1167 year: 2006 end-page: 1174 ident: bib0043 article-title: Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 publication-title: J Hepatol – volume: 21 start-page: 8293 year: 2002 end-page: 8301 ident: bib0072 article-title: New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism publication-title: Oncogene – volume: 134 start-page: 1655 year: 2008 end-page: 1669 ident: bib0056 article-title: Mechanisms of hepatic fibrogenesis publication-title: Gastroenterology – volume: 148 start-page: 1294 year: 2015 end-page: 1310 ident: bib0060 article-title: β-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis publication-title: Gastroenterology – volume: 139 start-page: 323 year: 2010 end-page: 334 ident: bib0048 article-title: Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice publication-title: Gastroenterology – volume: 25 start-page: 1653 year: 2017 end-page: 1664 ident: bib0126 article-title: Pharmacologic inhibition of β-catenin with pyrvinium inhibits murine and human models of Wilms tumor publication-title: Oncol Res – volume: 15 start-page: 45 year: 2017 ident: bib0035 article-title: Non-alcoholic fatty liver disease publication-title: BMC Med – volume: 92 start-page: 103 year: 1997 end-page: 112 ident: bib0059 article-title: Pathogenesis of liver fibrosis publication-title: Clin Sci (Lond) – volume: 26 start-page: 650 year: 2017 end-page: 661 ident: bib0115 article-title: Modulating the wnt signaling pathway with small molecules publication-title: Protein Sci – volume: 44 start-page: 2201 year: 2019 end-page: 2212 ident: bib0077 article-title: Role and mechanisms of action of microRNA-21 as regards the regulation of the WNT/β-catenin signaling pathway in the pathogenesis of non-alcoholic fatty liver disease publication-title: Int J Mol Med – volume: 279 start-page: 32345 year: 2004 end-page: 32353 ident: bib0088 article-title: Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease publication-title: J Biol Chem – volume: 122 start-page: 2871 year: 2012 end-page: 2883 ident: bib0112 article-title: Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver publication-title: J Clin Invest – volume: 44 start-page: 2256 year: 2019 end-page: 2264 ident: bib0132 article-title: The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice publication-title: Int J Mol Med – volume: 5 start-page: 743 year: 2010 end-page: 749 ident: bib0109 article-title: SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma publication-title: Epigenetics – volume: 48 start-page: 249 year: 2015 end-page: 258 ident: bib0124 article-title: Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling publication-title: Cell Prolif – volume: 59 start-page: 2344 year: 2014 end-page: 2357 ident: bib0071 article-title: T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice publication-title: Hepatology – volume: 13 start-page: 511 year: 2009 end-page: 531 ident: bib0012 article-title: Epidemiology and natural history of non-alcoholic steatohepatitis publication-title: Clin Liver Dis – volume: 29 start-page: 3436 year: 2015 end-page: 3445 ident: bib0086 article-title: Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a publication-title: FASEB J – volume: 287 start-page: 7213 year: 2012 end-page: 7223 ident: bib0079 article-title: Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure publication-title: J Biol Chem – volume: 294 start-page: G39 year: 2008 end-page: G49 ident: bib0091 article-title: Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis publication-title: Am J Physiol Gastrointest Liver Physiol – volume: 11 start-page: 183 year: 2005 end-page: 190 ident: bib0041 article-title: Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB publication-title: Nat Med – volume: 35 start-page: 2197 year: 2016 end-page: 2207 ident: bib0141 article-title: Wnt addiction of genetically defined cancers reversed by PORCN inhibition publication-title: Oncogene – volume: 58 start-page: 1419 year: 2009 end-page: 1425 ident: bib0013 article-title: Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men publication-title: Gut – volume: 2020 year: 2020 ident: bib0101 article-title: Heme oxygenase-1 suppresses Wnt signaling pathway in nonalcoholic steatohepatitis-related liver fibrosis publication-title: Biomed Res Int – volume: 42 start-page: 928 year: 2005 end-page: 940 ident: bib0037 article-title: NASH: a mitochondrial disease publication-title: J Hepatol – volume: 226 start-page: 2438 year: 2011 end-page: 2447 ident: bib0130 article-title: CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver publication-title: J Cell Physiol – volume: 18 start-page: 25 year: 2013 end-page: 26 ident: bib0131 article-title: CF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation study publication-title: Oncologist – volume: 26 start-page: 100 year: 2014 end-page: 107 ident: bib0057 article-title: Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer publication-title: Curr Opin Oncol – volume: 75 start-page: 1428 year: 2010 end-page: 1434 ident: bib0063 article-title: The Wnt/Frizzled GPCR signaling pathway publication-title: Biochemistry – volume: 162 start-page: 496 year: 2013 end-page: 500 ident: bib0024 article-title: Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010 publication-title: J Pediatr – volume: 6 start-page: 1 year: 2006 end-page: 28 ident: bib0038 article-title: Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it publication-title: Mitochondrion – volume: 44 start-page: 15495 year: 2005 end-page: 15503 ident: bib0121 article-title: Identification of a specific inhibitor of the dishevelled PDZ domain publication-title: Biochemistry – volume: 407 start-page: 535 year: 2000 end-page: 538 ident: bib0062 article-title: An LDL-receptor-related protein mediates Wnt signalling in mice publication-title: Nature – volume: 45 start-page: 195 year: 2007 end-page: 204 ident: bib0102 article-title: Wnt'er in liver: expression of Wnt and frizzled genes in mouse publication-title: Hepatology – volume: 5 start-page: 997 year: 2006 end-page: 1014 ident: bib0106 article-title: Mining the Wnt pathway for cancer therapeutics publication-title: Nat Rev Drug Discov – volume: 245 start-page: 1504 year: 2020 end-page: 1512 ident: bib0052 article-title: Endothelin-1 in portal hypertension: the intricate role of hepatic stellate cells publication-title: Exp Biol Med – volume: 71 start-page: 4028 year: 2011 end-page: 4039 ident: bib0110 article-title: EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis publication-title: Cancer Res – volume: 24 start-page: 2974 year: 2018 end-page: 2983 ident: bib0025 article-title: Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model" publication-title: World J Gastroenterol – volume: 111 start-page: 1645 year: 1996 end-page: 1653 ident: bib0039 article-title: Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation publication-title: Gastroenterology – volume: 7 start-page: 682 year: 2010 end-page: 690 ident: bib0053 article-title: Functional role of chemokines in liver disease models publication-title: Nat Rev Gastroenterol Hepatol – volume: 55 start-page: 415 year: 2006 end-page: 424 ident: bib0042 article-title: Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice publication-title: Gut – volume: 330 start-page: 505 year: 2005 end-page: 510 ident: bib0145 article-title: Wnt5b partially inhibits canonical Wnt/beta-catenin signaling pathway and promotes adipogenesis in 3T3-L1 preadipocytes publication-title: Biochem Biophys Res Commun – volume: 62 start-page: S47 year: 2015 end-page: S64 ident: bib0007 article-title: NAFLD: a multisystem disease publication-title: J Hepatol – volume: 15 start-page: 11 year: 2018 end-page: 20 ident: bib0004 article-title: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention publication-title: Nat Rev Gastroenterol Hepatol – volume: 75 start-page: 4803 year: 2015 end-page: 4816 ident: bib0111 article-title: Histone deacetylase HDAC8 promotes insulin resistance and β-catenin activation in NAFLD-associated hepatocellular carcinoma publication-title: Cancer Res – volume: 1864 start-page: 804 year: 2018 end-page: 818 ident: bib0144 article-title: Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis publication-title: Biochim Biophys Acta Mol Basis Dis – volume: 109 start-page: 11717 year: 2012 end-page: 11722 ident: bib0118 article-title: Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors publication-title: Proc Natl Acad Sci U S A – volume: 142 start-page: 687 year: 2010 end-page: 698 ident: bib0136 article-title: GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects publication-title: Cell – volume: 277 start-page: 210 year: 2014 end-page: 220 ident: bib0149 article-title: Morin ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by suppressing Wnt/β-catenin signaling publication-title: Toxicol Appl Pharmacol – volume: 163 start-page: 1301 year: 2003 end-page: 1311 ident: bib0032 article-title: Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease publication-title: Am J Pathol – volume: 18 start-page: 4233 year: 1999 end-page: 4240 ident: bib0065 article-title: Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1 publication-title: EMBO J – volume: 22 start-page: 10512 year: 2016 end-page: 10522 ident: bib0049 article-title: Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets publication-title: World J Gastroenterol – volume: 343 start-page: d3897 year: 2011 ident: bib0002 article-title: How big a problem is non-alcoholic fatty liver disease? publication-title: BMJ – volume: 16 start-page: 4243 year: 2010 end-page: 4252 ident: bib0015 article-title: Obstructive sleep apnea syndrome and fatty liver: association or causal link? publication-title: World J Gastroenterol – volume: 53 start-page: 372 year: 2010 end-page: 384 ident: bib0033 article-title: A position statement on NAFLD/NASH based on the EASL 2009 special conference publication-title: J Hepatol – volume: 2 start-page: 231 year: 2009 end-page: 237 ident: bib0017 article-title: A comprehensive definition for metabolic syndrome publication-title: Dis Model Mech – volume: 98 start-page: E60 year: 2013 end-page: E65 ident: bib0081 article-title: Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes publication-title: J Clin Endocrinol Metab – volume: 47 start-page: 1067 year: 2009 end-page: 1074 ident: bib0023 article-title: SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats publication-title: Free Radic Biol Med – volume: 7 start-page: 77707 year: 2016 end-page: 77720 ident: bib0078 article-title: SIRT1 suppresses adipogenesis by activating Wnt/β-catenin signaling publication-title: Oncotarget – volume: 8 start-page: e81710 year: 2013 ident: bib0120 article-title: Mutational analysis of sclerostin shows importance of the flexible loop and the cystine-knot for Wnt-signaling inhibition publication-title: PLoS One – volume: 15 start-page: 3 year: 2018 end-page: 13 ident: bib0076 article-title: Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases publication-title: Diab Vasc Dis Res – volume: 13 start-page: 4705 year: 2016 end-page: 4714 ident: bib0152 article-title: Herbal medicine Gan-fu-kang downregulates Wnt/Ca2+ signaling to attenuate liver fibrogenesis publication-title: Mol Med Rep – volume: 52 start-page: 1410 year: 2010 end-page: 1419 ident: bib0074 article-title: Liver-specific β-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis publication-title: Hepatology – volume: 28 start-page: 370 year: 2008 end-page: 379 ident: bib0031 article-title: Mechanisms of disease progression in nonalcoholic fatty liver disease publication-title: Semin Liver Dis – volume: 176 start-page: 744 year: 2010 end-page: 753 ident: bib0087 article-title: Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis publication-title: Am J Pathol – volume: 108 start-page: 12752 year: 2011 ident: 10.1016/j.hbpd.2022.10.003_bib0064 article-title: Deletion of mouse Porcn blocks Wnt ligand secretion and reveals an ectodermal etiology of human focal dermal hypoplasia/Goltz syndrome publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1006437108 – volume: 48 start-page: 249 year: 2015 ident: 10.1016/j.hbpd.2022.10.003_bib0124 article-title: Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling publication-title: Cell Prolif doi: 10.1111/cpr.12161 – volume: 407 start-page: 535 year: 2000 ident: 10.1016/j.hbpd.2022.10.003_bib0062 article-title: An LDL-receptor-related protein mediates Wnt signalling in mice publication-title: Nature doi: 10.1038/35035124 – volume: 7 start-page: 77707 year: 2016 ident: 10.1016/j.hbpd.2022.10.003_bib0078 article-title: SIRT1 suppresses adipogenesis by activating Wnt/β-catenin signaling in vivo and in vitro publication-title: Oncotarget doi: 10.18632/oncotarget.12774 – volume: 109 start-page: 11402 year: 2012 ident: 10.1016/j.hbpd.2022.10.003_bib0085 article-title: Chemical and genetic evidence for the involvement of Wnt antagonist Dickkopf2 in regulation of glucose metabolism publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1205015109 – volume: 98 start-page: E60 year: 2013 ident: 10.1016/j.hbpd.2022.10.003_bib0081 article-title: Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2012-3038 – volume: 136 year: 2020 ident: 10.1016/j.hbpd.2022.10.003_bib0138 article-title: The role of WNT/β-catenin signaling pathway and glutamine metabolism in the pathogenesis of CCl4-induced liver fibrosis: repositioning of niclosamide and concerns about lithium publication-title: Cytokine doi: 10.1016/j.cyto.2020.155250 – volume: 9 start-page: 208 year: 2009 ident: 10.1016/j.hbpd.2022.10.003_bib0083 article-title: The role of FOXO in the regulation of metabolism publication-title: Curr Diab Rep doi: 10.1007/s11892-009-0034-5 – volume: 28 start-page: 321 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0046 article-title: The sterile inflammatory response publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-030409-101311 – volume: 7 start-page: 682 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0053 article-title: Functional role of chemokines in liver disease models publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2010.168 – volume: 109 start-page: 11717 year: 2012 ident: 10.1016/j.hbpd.2022.10.003_bib0118 article-title: Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1120068109 – volume: 62 start-page: 1787 year: 2013 ident: 10.1016/j.hbpd.2022.10.003_bib0016 article-title: Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice publication-title: Gut doi: 10.1136/gutjnl-2012-303816 – volume: 40 start-page: 185 year: 2004 ident: 10.1016/j.hbpd.2022.10.003_bib0029 article-title: Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway publication-title: Hepatology doi: 10.1002/hep.20283 – volume: 122 start-page: 2871 year: 2012 ident: 10.1016/j.hbpd.2022.10.003_bib0112 article-title: Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver publication-title: J Clin Invest doi: 10.1172/JCI63539 – volume: 343 start-page: d3897 year: 2011 ident: 10.1016/j.hbpd.2022.10.003_bib0002 article-title: How big a problem is non-alcoholic fatty liver disease? publication-title: BMJ doi: 10.1136/bmj.d3897 – volume: 3 start-page: 680 year: 2012 ident: 10.1016/j.hbpd.2022.10.003_bib0117 article-title: An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid publication-title: Nat Commun doi: 10.1038/ncomms1680 – volume: 33 start-page: 1098 year: 2001 ident: 10.1016/j.hbpd.2022.10.003_bib0069 article-title: Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration publication-title: Hepatology doi: 10.1053/jhep.2001.23786 – volume: 47 start-page: 1067 year: 2009 ident: 10.1016/j.hbpd.2022.10.003_bib0023 article-title: SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2009.07.016 – volume: 15 start-page: s77 year: 2015 ident: 10.1016/j.hbpd.2022.10.003_bib0001 article-title: An overview of the genetics, mechanisms and management of NAFLD and ALD publication-title: Clin Med (Lond) doi: 10.7861/clinmedicine.15-6-s77 – volume: 29 start-page: 3436 year: 2015 ident: 10.1016/j.hbpd.2022.10.003_bib0086 article-title: Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a publication-title: FASEB J doi: 10.1096/fj.15-271171 – volume: 329 start-page: 454 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0089 article-title: Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity publication-title: Science doi: 10.1126/science.1188280 – volume: 142 start-page: 687 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0136 article-title: GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects publication-title: Cell doi: 10.1016/j.cell.2010.07.041 – volume: 10 year: 2015 ident: 10.1016/j.hbpd.2022.10.003_bib0116 article-title: Derricin and derricidin inhibit Wnt/β-catenin signaling and suppress colon cancer cell growth in vitro publication-title: PLoS One doi: 10.1371/journal.pone.0120919 – volume: 28 start-page: 370 year: 2008 ident: 10.1016/j.hbpd.2022.10.003_bib0031 article-title: Mechanisms of disease progression in nonalcoholic fatty liver disease publication-title: Semin Liver Dis doi: 10.1055/s-0028-1091981 – volume: 75 start-page: 1428 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0063 article-title: The Wnt/Frizzled GPCR signaling pathway publication-title: Biochemistry – volume: 330 start-page: 505 year: 2005 ident: 10.1016/j.hbpd.2022.10.003_bib0145 article-title: Wnt5b partially inhibits canonical Wnt/beta-catenin signaling pathway and promotes adipogenesis in 3T3-L1 preadipocytes publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2005.03.007 – volume: 431 start-page: 461 year: 2004 ident: 10.1016/j.hbpd.2022.10.003_bib0044 article-title: NF-kappaB functions as a tumour promoter in inflammation-associated cancer publication-title: Nature doi: 10.1038/nature02924 – volume: 171 start-page: 79 year: 2008 ident: 10.1016/j.hbpd.2022.10.003_bib0147 article-title: Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-Morin publication-title: Chem Biol Interact doi: 10.1016/j.cbi.2007.09.003 – volume: 26 start-page: 650 year: 2017 ident: 10.1016/j.hbpd.2022.10.003_bib0115 article-title: Modulating the wnt signaling pathway with small molecules publication-title: Protein Sci doi: 10.1002/pro.3122 – volume: 44 start-page: 1167 year: 2006 ident: 10.1016/j.hbpd.2022.10.003_bib0043 article-title: Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 publication-title: J Hepatol doi: 10.1016/j.jhep.2006.02.011 – volume: 22 start-page: 11 year: 2018 ident: 10.1016/j.hbpd.2022.10.003_bib0006 article-title: The natural history of nonalcoholic fatty liver disease-an evolving view publication-title: Clin Liver Dis doi: 10.1016/j.cld.2017.08.003 – volume: 45 start-page: 401 year: 2006 ident: 10.1016/j.hbpd.2022.10.003_bib0099 article-title: Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation publication-title: J Hepatol doi: 10.1016/j.jhep.2006.03.016 – volume: 15 start-page: 3 year: 2018 ident: 10.1016/j.hbpd.2022.10.003_bib0076 article-title: Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases publication-title: Diab Vasc Dis Res doi: 10.1177/1479164117738442 – volume: 62 start-page: S47 year: 2015 ident: 10.1016/j.hbpd.2022.10.003_bib0007 article-title: NAFLD: a multisystem disease publication-title: J Hepatol doi: 10.1016/j.jhep.2014.12.012 – volume: 33 start-page: 325 year: 2012 ident: 10.1016/j.hbpd.2022.10.003_bib0108 article-title: Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma publication-title: Tumour Biol doi: 10.1007/s13277-012-0331-5 – volume: 52 start-page: 1410 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0074 article-title: Liver-specific β-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis publication-title: Hepatology doi: 10.1002/hep.23801 – volume: 5 start-page: 997 year: 2006 ident: 10.1016/j.hbpd.2022.10.003_bib0106 article-title: Mining the Wnt pathway for cancer therapeutics publication-title: Nat Rev Drug Discov doi: 10.1038/nrd2154 – volume: 10 start-page: 237 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0020 article-title: Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey publication-title: BMC Public Health doi: 10.1186/1471-2458-10-237 – volume: 76 start-page: 891 year: 2016 ident: 10.1016/j.hbpd.2022.10.003_bib0143 article-title: A small-molecule antagonist of the β-catenin/TCF4 interaction blocks the self-renewal of cancer stem cells and suppresses tumorigenesis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-15-1519 – volume: 15 start-page: 45 year: 2017 ident: 10.1016/j.hbpd.2022.10.003_bib0035 article-title: Non-alcoholic fatty liver disease publication-title: BMC Med doi: 10.1186/s12916-017-0806-8 – volume: 26 start-page: 94 year: 2014 ident: 10.1016/j.hbpd.2022.10.003_bib0119 article-title: Secreted Frizzled-related protein potentiation versus inhibition of Wnt3a/β-catenin signaling publication-title: Cell Signal doi: 10.1016/j.cellsig.2013.09.016 – volume: 8 start-page: 282 year: 2014 ident: 10.1016/j.hbpd.2022.10.003_bib0095 article-title: Mest attenuates CCl4-induced liver fibrosis in rats by inhibiting the Wnt/β-catenin signaling pathway publication-title: Gut Liver doi: 10.5009/gnl.2014.8.3.282 – volume: 31 start-page: 184 year: 2015 ident: 10.1016/j.hbpd.2022.10.003_bib0009 article-title: Aging and liver disease publication-title: Curr Opin Gastroenterol doi: 10.1097/MOG.0000000000000176 – volume: 16 start-page: 3797 year: 1997 ident: 10.1016/j.hbpd.2022.10.003_bib0061 article-title: Beta-catenin is a target for the ubiquitin-proteasome pathway publication-title: EMBO J doi: 10.1093/emboj/16.13.3797 – volume: 7 start-page: 4453 year: 2015 ident: 10.1016/j.hbpd.2022.10.003_bib0080 article-title: Low-density lipoprotein receptor-related protein 6 (LRP6) is a novel nutritional therapeutic target for hyperlipidemia, non-alcoholic fatty liver disease, and atherosclerosis publication-title: Nutrients doi: 10.3390/nu7064453 – volume: 337 start-page: 98 year: 2009 ident: 10.1016/j.hbpd.2022.10.003_bib0014 article-title: Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans publication-title: Am J Med Sci doi: 10.1097/MAJ.0b013e3181812879 – volume: 9 start-page: 367 year: 2008 ident: 10.1016/j.hbpd.2022.10.003_bib0030 article-title: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm2391 – volume: 74 start-page: 193 year: 1998 ident: 10.1016/j.hbpd.2022.10.003_bib0058 article-title: Liver cirrhosis publication-title: Postgrad Med J doi: 10.1136/pgmj.74.870.193 – volume: 126 start-page: 1134 year: 2004 ident: 10.1016/j.hbpd.2022.10.003_bib0066 article-title: Beta-catenin is temporally regulated during normal liver development publication-title: Gastroenterology doi: 10.1053/j.gastro.2003.12.047 – volume: 71 start-page: 4028 year: 2011 ident: 10.1016/j.hbpd.2022.10.003_bib0110 article-title: EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-10-3342 – volume: 131 year: 2020 ident: 10.1016/j.hbpd.2022.10.003_bib0135 article-title: Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2020.110661 – volume: 289 start-page: 950 year: 2000 ident: 10.1016/j.hbpd.2022.10.003_bib0096 article-title: Inhibition of adipogenesis by Wnt signaling publication-title: Science doi: 10.1126/science.289.5481.950 – volume: 79 start-page: 376 year: 2012 ident: 10.1016/j.hbpd.2022.10.003_bib0123 article-title: Synthesis of potent dishevelled PDZ domain inhibitors guided by virtual screening and NMR studies publication-title: Chem Biol Drug Des doi: 10.1111/j.1747-0285.2011.01295.x – volume: 20 start-page: 8393 year: 2014 ident: 10.1016/j.hbpd.2022.10.003_bib0021 article-title: Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease publication-title: World J Gastroenterol doi: 10.3748/wjg.v20.i26.8393 – volume: 59 start-page: 2344 year: 2014 ident: 10.1016/j.hbpd.2022.10.003_bib0071 article-title: T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice publication-title: Hepatology doi: 10.1002/hep.26924 – volume: 25 start-page: 195 year: 2011 ident: 10.1016/j.hbpd.2022.10.003_bib0055 article-title: Mechanisms of hepatic fibrogenesis publication-title: Best Pract Res Clin Gastroenterol doi: 10.1016/j.bpg.2011.02.005 – volume: 132 start-page: 783 year: 2013 ident: 10.1016/j.hbpd.2022.10.003_bib0011 article-title: Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan publication-title: Hum Genet doi: 10.1007/s00439-013-1294-3 – volume: 131 start-page: 1561 year: 2006 ident: 10.1016/j.hbpd.2022.10.003_bib0068 article-title: Conditional deletion of beta-catenin reveals its role in liver growth and regeneration publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.08.042 – volume: 13 start-page: 4705 year: 2016 ident: 10.1016/j.hbpd.2022.10.003_bib0152 article-title: Herbal medicine Gan-fu-kang downregulates Wnt/Ca2+ signaling to attenuate liver fibrogenesis in vitro and in vivo publication-title: Mol Med Rep doi: 10.3892/mmr.2016.5148 – volume: 24 start-page: 908 year: 2018 ident: 10.1016/j.hbpd.2022.10.003_bib0018 article-title: Mechanisms of NAFLD development and therapeutic strategies publication-title: Nat Med doi: 10.1038/s41591-018-0104-9 – volume: 237 start-page: 436 year: 2022 ident: 10.1016/j.hbpd.2022.10.003_bib0050 article-title: Hepatic stellate cells in the injured liver: perspectives beyond hepatic fibrosis publication-title: J Cell Physiol doi: 10.1002/jcp.30582 – volume: 44 start-page: 57 year: 2006 ident: 10.1016/j.hbpd.2022.10.003_bib0051 article-title: TGF-beta/Smad signaling in the injured liver publication-title: Z Gastroenterol doi: 10.1055/s-2005-858989 – volume: 226 start-page: 2438 year: 2011 ident: 10.1016/j.hbpd.2022.10.003_bib0130 article-title: CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver publication-title: J Cell Physiol doi: 10.1002/jcp.22593 – volume: 92 start-page: 103 year: 1997 ident: 10.1016/j.hbpd.2022.10.003_bib0059 article-title: Pathogenesis of liver fibrosis publication-title: Clin Sci (Lond) doi: 10.1042/cs0920103 – volume: 5 start-page: e15521 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0127 article-title: Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling publication-title: PLoS One doi: 10.1371/journal.pone.0015521 – volume: 279 start-page: 32345 year: 2004 ident: 10.1016/j.hbpd.2022.10.003_bib0088 article-title: Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease publication-title: J Biol Chem doi: 10.1074/jbc.M313478200 – volume: 8 start-page: 575 year: 2018 ident: 10.1016/j.hbpd.2022.10.003_bib0107 article-title: Garlic-derived compound S-allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway publication-title: Acta Pharm Sin B doi: 10.1016/j.apsb.2017.10.003 – volume: 65 start-page: 1038 year: 2016 ident: 10.1016/j.hbpd.2022.10.003_bib0027 article-title: The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) publication-title: Metabolism doi: 10.1016/j.metabol.2015.12.012 – volume: 6 start-page: 1 year: 2006 ident: 10.1016/j.hbpd.2022.10.003_bib0038 article-title: Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it publication-title: Mitochondrion doi: 10.1016/j.mito.2005.10.004 – volume: 114 start-page: 842 year: 1998 ident: 10.1016/j.hbpd.2022.10.003_bib0026 article-title: Steatohepatitis: a tale of two "hits"? publication-title: Gastroenterology doi: 10.1016/S0016-5085(98)70599-2 – volume: 374 start-page: 13 year: 2013 ident: 10.1016/j.hbpd.2022.10.003_bib0100 article-title: Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through promoting the ROS production publication-title: Mol Cell Biochem doi: 10.1007/s11010-012-1498-1 – volume: 287 start-page: 187 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0150 article-title: Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice publication-title: Cancer Lett doi: 10.1016/j.canlet.2009.06.009 – volume: 69 start-page: S29 year: 2016 ident: 10.1016/j.hbpd.2022.10.003_bib0140 article-title: Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC) publication-title: Eur J Cancer doi: 10.1016/S0959-8049(16)32668-5 – volume: 16 start-page: 1941 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0028 article-title: Insulin resistance in nonalcoholic fatty liver disease publication-title: Curr Pharm Des doi: 10.2174/138161210791208875 – volume: 8 year: 2021 ident: 10.1016/j.hbpd.2022.10.003_bib0104 article-title: Sirt1 promotes the restoration of hepatic progenitor cell (HPC)-mediated liver fatty injury in NAFLD through activating the Wnt/β-catenin signal pathway publication-title: Front Nutr doi: 10.3389/fnut.2021.791861 – volume: 21 start-page: 44 year: 2011 ident: 10.1016/j.hbpd.2022.10.003_bib0070 article-title: Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2010.12.010 – volume: 25 start-page: 1653 year: 2017 ident: 10.1016/j.hbpd.2022.10.003_bib0126 article-title: Pharmacologic inhibition of β-catenin with pyrvinium inhibits murine and human models of Wilms tumor publication-title: Oncol Res doi: 10.3727/096504017X14992942781895 – volume: 24 start-page: 2974 year: 2018 ident: 10.1016/j.hbpd.2022.10.003_bib0025 article-title: Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model" publication-title: World J Gastroenterol doi: 10.3748/wjg.v24.i27.2974 – volume: 162 start-page: 496 year: 2013 ident: 10.1016/j.hbpd.2022.10.003_bib0024 article-title: Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010 publication-title: J Pediatr doi: 10.1016/j.jpeds.2012.08.043 – volume: 16 start-page: 4243 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0015 article-title: Obstructive sleep apnea syndrome and fatty liver: association or causal link? publication-title: World J Gastroenterol doi: 10.3748/wjg.v16.i34.4243 – volume: 26 start-page: 100 year: 2014 ident: 10.1016/j.hbpd.2022.10.003_bib0057 article-title: Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer publication-title: Curr Opin Oncol doi: 10.1097/CCO.0000000000000042 – volume: 64 start-page: 73 year: 2016 ident: 10.1016/j.hbpd.2022.10.003_bib0005 article-title: Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes publication-title: Hepatology doi: 10.1002/hep.28431 – volume: 51 start-page: 371 year: 2009 ident: 10.1016/j.hbpd.2022.10.003_bib0008 article-title: Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis publication-title: J Hepatol doi: 10.1016/j.jhep.2009.03.019 – volume: 245 start-page: 1504 year: 2020 ident: 10.1016/j.hbpd.2022.10.003_bib0052 article-title: Endothelin-1 in portal hypertension: the intricate role of hepatic stellate cells publication-title: Exp Biol Med doi: 10.1177/1535370220949148 – volume: 65 start-page: 1024 year: 2016 ident: 10.1016/j.hbpd.2022.10.003_bib0113 article-title: Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations publication-title: Gut doi: 10.1136/gutjnl-2014-308969 – volume: 8 start-page: e81710 year: 2013 ident: 10.1016/j.hbpd.2022.10.003_bib0120 article-title: Mutational analysis of sclerostin shows importance of the flexible loop and the cystine-knot for Wnt-signaling inhibition publication-title: PLoS One doi: 10.1371/journal.pone.0081710 – volume: 37 start-page: 62 year: 2017 ident: 10.1016/j.hbpd.2022.10.003_bib0114 article-title: Sirt1 suppresses Wnt/βCatenin signaling in liver cancer cells by targeting βCatenin in a PKAα-dependent manner publication-title: Cell Signal doi: 10.1016/j.cellsig.2017.06.001 – volume: 18 start-page: 25 year: 2013 ident: 10.1016/j.hbpd.2022.10.003_bib0131 article-title: CF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation study publication-title: Oncologist doi: 10.1634/theoncologist.2012-0211 – volume: 58 start-page: 1419 year: 2009 ident: 10.1016/j.hbpd.2022.10.003_bib0013 article-title: Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men publication-title: Gut doi: 10.1136/gut.2008.161885 – volume: 38 start-page: 320 year: 2006 ident: 10.1016/j.hbpd.2022.10.003_bib0084 article-title: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes publication-title: Nat Genet doi: 10.1038/ng1732 – volume: 44 start-page: 2201 year: 2019 ident: 10.1016/j.hbpd.2022.10.003_bib0077 article-title: Role and mechanisms of action of microRNA-21 as regards the regulation of the WNT/β-catenin signaling pathway in the pathogenesis of non-alcoholic fatty liver disease publication-title: Int J Mol Med – volume: 11 year: 2016 ident: 10.1016/j.hbpd.2022.10.003_bib0105 article-title: Macrophage activation in pediatric nonalcoholic fatty liver disease (NAFLD) correlates with hepatic progenitor cell response via Wnt3a pathway publication-title: PLoS One doi: 10.1371/journal.pone.0157246 – volume: 280 start-page: 4959 year: 2005 ident: 10.1016/j.hbpd.2022.10.003_bib0098 article-title: Adipogenic transcriptional regulation of hepatic stellate cells publication-title: J Biol Chem doi: 10.1074/jbc.M410078200 – volume: 111 start-page: 1645 year: 1996 ident: 10.1016/j.hbpd.2022.10.003_bib0039 article-title: Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation publication-title: Gastroenterology doi: 10.1016/S0016-5085(96)70028-8 – volume: 42 start-page: 928 year: 2005 ident: 10.1016/j.hbpd.2022.10.003_bib0037 article-title: NASH: a mitochondrial disease publication-title: J Hepatol doi: 10.1016/j.jhep.2005.03.004 – volume: 167 start-page: 1279 year: 2005 ident: 10.1016/j.hbpd.2022.10.003_bib0067 article-title: Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)61215-1 – volume: 43 start-page: 817 year: 2006 ident: 10.1016/j.hbpd.2022.10.003_bib0073 article-title: Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice publication-title: Hepatology doi: 10.1002/hep.21131 – volume: 45 start-page: 195 year: 2007 ident: 10.1016/j.hbpd.2022.10.003_bib0102 article-title: Wnt'er in liver: expression of Wnt and frizzled genes in mouse publication-title: Hepatology doi: 10.1002/hep.21473 – volume: 94 start-page: 2467 year: 1999 ident: 10.1016/j.hbpd.2022.10.003_bib0003 article-title: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.1999.01377.x – volume: 294 start-page: G39 year: 2008 ident: 10.1016/j.hbpd.2022.10.003_bib0091 article-title: Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00263.2007 – volume: 163 start-page: 1301 year: 2003 ident: 10.1016/j.hbpd.2022.10.003_bib0032 article-title: Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)63489-X – volume: 20 start-page: 1263 year: 2014 ident: 10.1016/j.hbpd.2022.10.003_bib0137 article-title: Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice publication-title: Nat Med doi: 10.1038/nm.3699 – volume: 12 start-page: 40 year: 1999 ident: 10.1016/j.hbpd.2022.10.003_bib0134 article-title: Current and emerging azole antifungal agents publication-title: Clin Microbiol Rev doi: 10.1128/CMR.12.1.40 – volume: 287 start-page: 7213 year: 2012 ident: 10.1016/j.hbpd.2022.10.003_bib0079 article-title: Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure publication-title: J Biol Chem doi: 10.1074/jbc.M111.286724 – volume: 18 start-page: 4233 year: 1999 ident: 10.1016/j.hbpd.2022.10.003_bib0065 article-title: Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1 publication-title: EMBO J doi: 10.1093/emboj/18.15.4233 – volume: 18 start-page: 1745 year: 2012 ident: 10.1016/j.hbpd.2022.10.003_bib0093 article-title: Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays publication-title: World J Gastroenterol doi: 10.3748/wjg.v18.i15.1745 – volume: 55 start-page: 415 year: 2006 ident: 10.1016/j.hbpd.2022.10.003_bib0042 article-title: Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice publication-title: Gut doi: 10.1136/gut.2005.071118 – volume: 4 start-page: ra6 year: 2011 ident: 10.1016/j.hbpd.2022.10.003_bib0082 article-title: Wnt signaling regulates hepatic metabolism publication-title: Sci Signal doi: 10.1126/scisignal.2001249 – volume: 12 start-page: 1848 year: 2013 ident: 10.1016/j.hbpd.2022.10.003_bib0125 article-title: Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-13-0048 – volume: 37 start-page: 7 year: 2018 ident: 10.1016/j.hbpd.2022.10.003_bib0151 article-title: The plant alkaloid tetrandrine inhibits metastasis via autophagy-dependent Wnt/β-catenin and metastatic tumor antigen 1 signaling in human liver cancer cells publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-018-0678-6 – volume: 44 start-page: 2256 year: 2019 ident: 10.1016/j.hbpd.2022.10.003_bib0132 article-title: The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice publication-title: Int J Mol Med – volume: 67 start-page: 91 year: 2000 ident: 10.1016/j.hbpd.2022.10.003_bib0146 article-title: Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs publication-title: Life Sci doi: 10.1016/S0024-3205(00)00605-6 – volume: 581 start-page: 2954 year: 2007 ident: 10.1016/j.hbpd.2022.10.003_bib0092 article-title: Wnt signaling enhances the activation and survival of human hepatic stellate cells publication-title: FEBS Lett doi: 10.1016/j.febslet.2007.05.050 – volume: 35 start-page: 2197 year: 2016 ident: 10.1016/j.hbpd.2022.10.003_bib0141 article-title: Wnt addiction of genetically defined cancers reversed by PORCN inhibition publication-title: Oncogene doi: 10.1038/onc.2015.280 – volume: 5 start-page: 743 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0109 article-title: SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma publication-title: Epigenetics doi: 10.4161/epi.5.8.13104 – volume: 148 start-page: 1294 year: 2015 ident: 10.1016/j.hbpd.2022.10.003_bib0060 article-title: β-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.02.056 – volume: 118 start-page: 829 year: 2008 ident: 10.1016/j.hbpd.2022.10.003_bib0034 article-title: Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice publication-title: J Clin Invest doi: 10.1172/JCI34275 – volume: 279 start-page: 11392 year: 2004 ident: 10.1016/j.hbpd.2022.10.003_bib0097 article-title: Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells publication-title: J Biol Chem doi: 10.1074/jbc.M310284200 – volume: 47 start-page: 1018 year: 2008 ident: 10.1016/j.hbpd.2022.10.003_bib0103 article-title: Wnt2 acts as a cell type-specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway publication-title: Hepatology doi: 10.1002/hep.22084 – volume: 15 year: 2020 ident: 10.1016/j.hbpd.2022.10.003_bib0139 article-title: Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs publication-title: PLoS One – volume: 17 start-page: 89 year: 2001 ident: 10.1016/j.hbpd.2022.10.003_bib0090 article-title: Genomic analysis of differentially expressed genes in liver and biliary epithelial cells of patients with primary biliary cirrhosis publication-title: J Autoimmun doi: 10.1006/jaut.2001.0522 – volume: 39 start-page: 913 year: 2019 ident: 10.1016/j.hbpd.2022.10.003_bib0154 article-title: Diwu Yanggan modulates the Wnt/β-catenin pathway and inhibits liver carcinogenesis signaling in 2-AAF/PH model rats publication-title: Curr Med Sci doi: 10.1007/s11596-019-2123-2 – volume: 9 start-page: 2145 year: 2014 ident: 10.1016/j.hbpd.2022.10.003_bib0094 article-title: Zhu L. β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation publication-title: Mol Med Rep doi: 10.3892/mmr.2014.2099 – volume: 21 start-page: 8293 year: 2002 ident: 10.1016/j.hbpd.2022.10.003_bib0072 article-title: New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism publication-title: Oncogene doi: 10.1038/sj.onc.1206118 – volume: 9 start-page: e83819 year: 2014 ident: 10.1016/j.hbpd.2022.10.003_bib0129 article-title: Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression publication-title: PLoS One doi: 10.1371/journal.pone.0083819 – volume: 284 start-page: 16256 year: 2009 ident: 10.1016/j.hbpd.2022.10.003_bib0122 article-title: Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled publication-title: J Biol Chem doi: 10.1074/jbc.M109.009647 – volume: 22 start-page: 10512 year: 2016 ident: 10.1016/j.hbpd.2022.10.003_bib0049 article-title: Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets publication-title: World J Gastroenterol doi: 10.3748/wjg.v22.i48.10512 – volume: 444 start-page: 860 year: 2006 ident: 10.1016/j.hbpd.2022.10.003_bib0040 article-title: Inflammation and metabolic disorders publication-title: Nature doi: 10.1038/nature05485 – volume: 44 start-page: 15495 year: 2005 ident: 10.1016/j.hbpd.2022.10.003_bib0121 article-title: Identification of a specific inhibitor of the dishevelled PDZ domain publication-title: Biochemistry doi: 10.1021/bi0512602 – volume: 2 start-page: 231 year: 2009 ident: 10.1016/j.hbpd.2022.10.003_bib0017 article-title: A comprehensive definition for metabolic syndrome publication-title: Dis Model Mech doi: 10.1242/dmm.001180 – volume: 10 start-page: 330 year: 2013 ident: 10.1016/j.hbpd.2022.10.003_bib0022 article-title: Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2013.41 – volume: 139 start-page: 323 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0048 article-title: Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice publication-title: Gastroenterology doi: 10.1053/j.gastro.2010.03.052 – volume: 1864 start-page: 804 year: 2018 ident: 10.1016/j.hbpd.2022.10.003_bib0144 article-title: Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12 publication-title: Biochim Biophys Acta Mol Basis Dis doi: 10.1016/j.bbadis.2017.12.001 – volume: 66 start-page: 55 year: 2017 ident: 10.1016/j.hbpd.2022.10.003_bib0019 article-title: Non-alcoholic fatty liver disease with and without metabolic syndrome: different long-term outcomes publication-title: Metabolism doi: 10.1016/j.metabol.2016.06.009 – volume: 74 start-page: 743 year: 2003 ident: 10.1016/j.hbpd.2022.10.003_bib0148 article-title: Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock publication-title: Life Sci doi: 10.1016/j.lfs.2003.07.017 – volume: 75 start-page: 1691 year: 2015 ident: 10.1016/j.hbpd.2022.10.003_bib0142 article-title: Wnt/β-catenin small-molecule inhibitor CWP232228 preferentially inhibits the growth of breast cancer stem-like cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-14-2041 – volume: 51 start-page: 511 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0047 article-title: Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity publication-title: Hepatology doi: 10.1002/hep.23337 – volume: 40 start-page: 1461 year: 2008 ident: 10.1016/j.hbpd.2022.10.003_bib0010 article-title: Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease publication-title: Nat Genet doi: 10.1038/ng.257 – volume: 13 start-page: 511 year: 2009 ident: 10.1016/j.hbpd.2022.10.003_bib0012 article-title: Epidemiology and natural history of non-alcoholic steatohepatitis publication-title: Clin Liver Dis doi: 10.1016/j.cld.2009.07.005 – volume: 296 start-page: G1248 year: 2009 ident: 10.1016/j.hbpd.2022.10.003_bib0045 article-title: Inflammasome-mediated regulation of hepatic stellate cells publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.90223.2008 – volume: 136 start-page: 133 year: 2018 ident: 10.1016/j.hbpd.2022.10.003_bib0153 article-title: Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing NF-κB signaling and Wnt/β-catenin signaling publication-title: J Pharmacol Sci doi: 10.1016/j.jphs.2018.01.003 – volume: 99 start-page: 1497 year: 2004 ident: 10.1016/j.hbpd.2022.10.003_bib0036 article-title: Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2004.30159.x – volume: 177 year: 2020 ident: 10.1016/j.hbpd.2022.10.003_bib0128 article-title: Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2020.113942 – volume: 131 start-page: 411 year: 2009 ident: 10.1016/j.hbpd.2022.10.003_bib0075 article-title: Knockdown of tight junction protein claudin-2 prevents bile canalicular formation in WIF-B9 cells publication-title: Histochem Cell Biol doi: 10.1007/s00418-008-0546-0 – volume: 134 start-page: 1655 year: 2008 ident: 10.1016/j.hbpd.2022.10.003_bib0056 article-title: Mechanisms of hepatic fibrogenesis publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.03.003 – volume: 176 start-page: 744 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0087 article-title: Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis publication-title: Am J Pathol doi: 10.2353/ajpath.2010.090667 – volume: 2020 year: 2020 ident: 10.1016/j.hbpd.2022.10.003_bib0101 article-title: Heme oxygenase-1 suppresses Wnt signaling pathway in nonalcoholic steatohepatitis-related liver fibrosis publication-title: Biomed Res Int doi: 10.1155/2020/4910601 – volume: 15 start-page: 11 year: 2018 ident: 10.1016/j.hbpd.2022.10.003_bib0004 article-title: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2017.109 – volume: 110 start-page: 371 year: 2019 ident: 10.1016/j.hbpd.2022.10.003_bib0155 article-title: Dendrobium candidum extract inhibits proliferation and induces apoptosis of liver cancer cells by inactivating Wnt/β-catenin signaling pathway publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2018.11.149 – volume: 53 start-page: 372 year: 2010 ident: 10.1016/j.hbpd.2022.10.003_bib0033 article-title: A position statement on NAFLD/NASH based on the EASL 2009 special conference publication-title: J Hepatol doi: 10.1016/j.jhep.2010.04.008 – volume: 12 start-page: 768 year: 2016 ident: 10.1016/j.hbpd.2022.10.003_bib0133 article-title: Inhibition of wnt/β-catenin signaling in hepatocellular carcinoma by an antipsychotic drug pimozide publication-title: Int J Biol Sci doi: 10.7150/ijbs.14718 – volume: 11 start-page: 183 year: 2005 ident: 10.1016/j.hbpd.2022.10.003_bib0041 article-title: Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB publication-title: Nat Med doi: 10.1038/nm1166 – volume: 75 start-page: 4803 year: 2015 ident: 10.1016/j.hbpd.2022.10.003_bib0111 article-title: Histone deacetylase HDAC8 promotes insulin resistance and β-catenin activation in NAFLD-associated hepatocellular carcinoma publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-14-3786 – volume: 277 start-page: 210 year: 2014 ident: 10.1016/j.hbpd.2022.10.003_bib0149 article-title: Morin ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by suppressing Wnt/β-catenin signaling publication-title: Toxicol Appl Pharmacol doi: 10.1016/j.taap.2014.03.008 – volume: 109 start-page: E3186 year: 2012 ident: 10.1016/j.hbpd.2022.10.003_bib0054 article-title: Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1119964109 |
SSID | ssj0028856 |
Score | 2.4668748 |
SecondaryResourceType | review_article |
Snippet | Nonalcoholic fatty liver disease (NAFLD) is a global health concern associated with significant morbidity and mortality. NAFLD is a spectrum of diseases... Nonalcoholic fatty liver disease(NAFLD)is a global health concern associated with significant morbidity and mortality.NAFLD is a spectrum of diseases... |
SourceID | wanfang proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 333 |
SubjectTerms | Chronic liver diseases Fatty liver Fibrosis Oxidative stress Steatosis Wnt/β-catenin |
Title | Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1499387222002399 https://dx.doi.org/10.1016/j.hbpd.2022.10.003 https://www.ncbi.nlm.nih.gov/pubmed/36448560 https://www.proquest.com/docview/2743507999 https://d.wanfangdata.com.cn/periodical/gjgdybzz-z202304003 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEB6SDZReSv-7bRNUyK04a-vP8jGEhG1DcmlCcxOSJW8dUu8SO4fsofQR-ox9kmrW8tJSmkJOBtlji5E88w2abwZgl3IrqeUiUZnxCTeSJsarNBGlTb0Stsok8p1PTuX0nH-8EBcbcDBwYTCtMtr-3qavrHUcmURtThZ1PfkUsH3BVB4cXM_Q3IStcKFqBFv7H46np-u4SynRk4yKAkvJ0sid6dO8vtgFFgyldG-V5MX-5Z_-xp8rmk9TmWb2m0c6egyPIpQk-_1sn8CGb57Cg5N4WP4Mzj433cT6zvz8_gPznpq6IZiuYZCBTkzjSN215OvcYQev-XVLwv0GgfmqaW5dksp03S25wswNEg9y2udwfnR4djBNYhOFpOScdYmnWZnJUgqfW8epKaqiSq11pqxM7oK7r1KWK5dnpQqxlEtzyl0ABcoxaVNlOHsBo_Bt_wqIk4bnzBaW25I7KazlnAsjhTM-qygdQzaoTpexwjg2urjSQyrZpUZ1a1Q3jgV1j-H9WmbR19e482k2rIgemKPB1ulg_u-UEmupP_bWf-XeDYuuw0-HJymm8fObVodQngUgHcD1GF72u2E9e4YRb8CRY9iN20NHs9Dq2eXM3drlUi-xaz3aT_b6npN7Aw_xHX0u4lsYddc3fjvgo87uwObet2wn_gW_ABm_Dz0 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VrQRcEG-Wp5F6Q2ETv-Icq4pqS7t7YSt6s-zYWVKV7KqbHronfgK_kV-CZ-OsQIgicXUyiTW2Z76Rv5kB2KPcSmq5SFRmfMKNpInxKk1EaVOvhK0yifnOk6kcn_KPZ-JsBw76XBikVUbb39n0jbWOI6OozdGyrkefArYvmMqDg-syNG_BLsem1gPY3T86Hk-3cZdSoksyKgosJUtj7kxH8_pil1gwlNL3G5IX-5t_-hN_btJ8mso081880uF9uBehJNnvZvsAdnzzEG5P4mX5I5h9btqR9a358e078p6auiFI1zCYgU5M40jdrsjXhcMOXovLFQnPGwTmm6a5dUkq07bX5AKZGyRe5Kwew-nhh9nBOIlNFJKSc9YmnmZlJkspfG4dp6aoiiq11pmyMrkL7r5KWa5cnpUqxFIuzSl3ARQox6RNleHsCQzCv_0zIE4anjNbWG5L7qSwlnMujBTO-KyidAhZrzpdxgrj2OjiQvdUsnON6taobhwL6h7Cu63MsquvcePbrF8R3WeOBlung_m_UUpspX7bW_-Ue9svug6HDm9STOMXVysdQnkWgHQA10N42u2G7ewZRrwBRw5hL24PHc3CSs_P5-7artd6jV3r0X6y5_85uTdwZzybnOiTo-nxC7iL3-t4iS9h0F5e-VcBK7X2dTwLPwF7hREj |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Wnt%2Fbeta-catenin+signaling+and+its+modulators+in+nonalcoholic+fatty+liver+diseases&rft.jtitle=Hepatobiliary+%26+pancreatic+diseases+international&rft.au=Shree+Harini%2C+Karthik&rft.au=Ezhilarasan%2C+Devaraj&rft.date=2023-08-01&rft.issn=1499-3872&rft.volume=22&rft.issue=4&rft.spage=333&rft_id=info:doi/10.1016%2Fj.hbpd.2022.10.003&rft.externalDBID=NO_FULL_TEXT |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fgjgdybzz-z%2Fgjgdybzz-z.jpg |